<SEC-DOCUMENT>0001193125-24-045485.txt : 20240226
<SEC-HEADER>0001193125-24-045485.hdr.sgml : 20240226
<ACCEPTANCE-DATETIME>20240226090312
ACCESSION NUMBER:		0001193125-24-045485
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240226
DATE AS OF CHANGE:		20240226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Digimarc CORP
		CENTRAL INDEX KEY:			0001438231
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				262828185
		STATE OF INCORPORATION:			OR
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272903
		FILM NUMBER:		24673781

	BUSINESS ADDRESS:	
		STREET 1:		8500 SW CREEKSIDE PLACE
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97008
		BUSINESS PHONE:		503-469-4800

	MAIL ADDRESS:	
		STREET 1:		8500 SW CREEKSIDE PLACE
		CITY:			BEAVERTON
		STATE:			OR
		ZIP:			97008

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DMRC CORP
		DATE OF NAME CHANGE:	20080620
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d774116d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) <BR>Registration No. 333-272903 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To Prospectus dated July&nbsp;19,
2023) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>928,571 Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DIGIMARC CORPORATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g774116g45f56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are selling
928,571 shares of our common stock in a registered direct offering to certain purchasers in a privately negotiated transaction pursuant to this prospectus supplement at a price of $35.00 per share. We have not retained an underwriter or placement
agent with respect to this offering and therefore are not paying any underwriting discounts or commissions. We estimate the total expenses of this offering will be $240,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#147;DMRC.&#148; The last reported sale price of our common
stock on the Nasdaq Global Select Market on February&nbsp;23, 2024 was $35.87 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our common stock involves risks. See &#147;<A HREF="#supptoc774116_4">Risk&nbsp;Factors</A>&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-5</FONT> of this prospectus supplement and on page&nbsp;3&nbsp;of the accompanying
prospectus. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission, any state securities commission, nor any other regulatory body has
approved or disapproved of these securities or determined if this prospectus supplement and the prospectus to which it relates are truthful and complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registered Direct Offering Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds to Digimarc Corporation (before expenses)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is February 26, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_2">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_3">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_6">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_7">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_8">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_9">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_10">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc774116_11">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_2">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_6">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_7">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_8">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_9">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_14">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second
part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the &#147;prospectus,&#148; we are referring to both parts combined. If information in the
prospectus supplement conflicts with information in the accompanying base prospectus, you should rely on the information in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will be
deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus supplement or in any other subsequently filed document that is also incorporated by reference into this prospectus
modifies or supersedes that statement. Any statements so modified or superseded will be deemed not to constitute a part of this prospectus except as so modified or superseded. Before you invest, you should carefully read this prospectus and the
information contained in the documents we refer to under the headings &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained or incorporated by reference in this prospectus. We have not authorized anyone to provide
you with additional or different information. The prospectus may be used only for the purposes for which it has been published. If you receive any other information, you should not rely on it. You should assume that the information contained in this
prospectus is accurate only as of the date on the front cover. Our business, financial condition, results of operations or prospects may have changed since that date. You should not rely on or assume the accuracy of any representation or warranty in
any agreement that we have filed as an exhibit to the registration statement of which this prospectus is a part or that we may otherwise publicly file in the future because any such representation or warranty may be subject to exceptions and
qualifications contained in separate disclosure schedules, may represent the parties&#146; risk allocation in the particular transaction, may be qualified by materiality standards that differ from what may be viewed as material for securities law
purposes or may no longer continue to be true as of any given date. No offer of these securities is being made in any jurisdiction where such offer or sale is prohibited. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Unless we otherwise specify, when used in this prospectus supplement, the terms &#147;Digimarc,&#148; the &#147;Company,&#148;
&#147;we,&#148; &#147;our&#148; and &#147;us&#148; refer to Digimarc Corporation and its subsidiaries, except that when such terms are used in this prospectus supplement in reference to the common shares, they refer specifically to Digimarc
Corporation. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_2"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and documents incorporated herein by reference include &#147;forward-looking statements&#148; within the meaning of
Section&nbsp;21E of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) and Section&nbsp;27A of the Securities Act of 1933 (the &#147;Securities Act&#148;). Words such as &#147;may,&#148; &#147;plan,&#148; &#147;should,&#148;
&#147;could,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148; &#147;project,&#148; &#147;forecast,&#148; &#147;estimate,&#148; &#147;continue,&#148; variations of such terms or similar expressions are
intended to identify such forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements, or other statements made by us, are made based
on our expectations and beliefs concerning future events affecting us, and are subject to uncertainties and factors (including those specified below) that are difficult to predict and, in many instances, are beyond our control. As a result, our
actual results could differ materially from those expressed in or implied by any <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements, and investors are cautioned not to place undue reliance on these statements. <FONT
STYLE="white-space:nowrap">Forward-looking</FONT> statements include, but are not limited to, statements relating to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the proceeds of this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the acquisition of EVRYTHNG Limited and its impact on our business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the concentration of most of our revenue among few customers and the trends and sources of future revenue;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated successful advocacy of our technology by our partners; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our belief regarding the global deployment of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding potential outcomes of participating in the HolyGrail 2.0 initiative and the utility of our
products in the recycling industry; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future level of investment in our business, including investment in research, development and engineering of
products and technology, development of our intellectual property, sales growth initiatives and development of new market opportunities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated expenses, costs, margins, provision for income taxes and investment activities in the foreseeable
future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our assumptions and expectations related to stock awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our belief that we have one of the world&#146;s most extensive patent portfolios in digital watermarking and
related fields; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated effect of our adoption of accounting pronouncements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding our critical accounting policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the impact of accounting pronouncements issued but not yet adopted;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated revenue to be generated from current contracts, renewals, and as a result of new programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates, judgments and assumptions related to impairment testing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variability of contracted arrangements in response to changes in circumstances underlying the original
contractual arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business opportunities that could require that we seek additional financing and our ability to do so;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth of our markets and our assumptions and beliefs related to those markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the existence of international growth opportunities and our future investment in such opportunities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected short-term and long-term liquidity positions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our capital expenditure and working capital requirements and our ability to fund our capital expenditure and
working capital needs through cash flow from operations or financing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our ability to meet future financial obligations as they become due within the coming
fiscal year; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of computerized trading on our stock price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capital market conditions, our expectations regarding credit risk exposure, interest rate volatility and other
limitations on the availability of capital, which could have an impact on our cost of capital and our ability to access the capital markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strength of our competitive position and our ability to innovate and enhance our competitive differentiation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to our existing facilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">protection, development and monetization of our intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding cybersecurity incidents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to certain provisions in our bylaws and articles of incorporation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to legal proceedings and claims arising in the ordinary course of business; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks detailed in our filings with the SEC, including the risk factors set forth in Part I, Item 1A of our
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2022 (our &#147;2022 Annual Report&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the risk factors specified below and the risk factors identified in Part I, Item 1A of our 2022 Annual Report, among others,
could affect our future performance and the liquidity and value of our securities and cause our actual results to differ materially from those expressed or implied by forward-looking statements made by us or on our behalf. Investors should
understand that it is not possible to predict or identify all risk factors and that there may be other factors that may cause our actual results to differ materially from the forward-looking statements. All forward-looking statements made by us or
by persons acting on our behalf apply only as of the date of this prospectus supplement. We do not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise
after the date of the filing of this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_3"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>928,571 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding after this offering </P></TD>
<TD>21,372,167 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We intend to use the net proceeds of this offering of shares of our common stock, after deducting our offering expenses, for general corporate purposes. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq Symbol </P></TD>
<TD>DMRC </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>An investment in our common shares involves risks. You should carefully consider each of the factors described or referred to under &#147;Risk Factors&#148; beginning on page S-4 of this prospectus supplement, page 3 of the accompanying
prospectus and in the documents incorporated by reference into this prospectus supplement and accompanying prospectus before you make an investment in our common stock. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding after this offering is based on 20,443,596 shares of common stock outstanding as of
February&nbsp;23, 2024 and excludes an aggregate of 768,000 shares of our common stock issuable pursuant to outstanding stock awards and 1,250,000 shares reserved for future issuance under our equity incentive plans as of February&nbsp;23, 2024.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all information in this prospectus supplement assumes no exercise of outstanding options to purchase shares
of common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in our common stock involves a high degree of risk. The following risk factors are risks of which we are aware and that we
consider to be material to this offering of shares of our common stock. You should also consider the risks, uncertainties and assumptions discussed under the heading &#147;Risk Factors&#148; included in Part I, Item 1A of our 2022 Annual Report and
other reports that we file with the SEC, which are on file with the SEC and are incorporated herein by reference, and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. If any of
the following risks and uncertainties develops into actual events, our business, financial condition or results of operations and cash flows could be materially adversely affected. In that case, the trading price of our common stock could decline
and you could lose all or part of your investment. Additionally, we cannot be certain or give any assurance that any actions taken to reduce known risks and uncertainties will be effective. Before investing in our common stock, you should carefully
consider the risks described below, together with all of the other information contained in this prospectus supplement and the accompanying prospectus and incorporated by reference herein and therein, including from our 2022 Annual Report and
Periodic Reports on Form 8-K. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to This Offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A substantial number of shares of our common stock will be sold in this offering, which could cause the price of our common stock to decline.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this offering we will sell 928,571 shares of common stock, which represent approximately 4.3% of our outstanding common stock
as of February&nbsp;23, 2024, after giving effect to the sale of the shares of common stock. This sale and any future sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur,
could adversely affect the price of our common stock on the Nasdaq Global Select Market. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares of common stock for sale will have
on the market price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we do not expect to pay cash dividends for the foreseeable future, you must rely on appreciation
of our common stock price for any return on your investment. Even if we change that policy, we may be restricted from paying dividends on our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not intend to pay cash dividends on shares of our common stock for the foreseeable future. Accordingly, you will have to rely on capital
appreciation, if any, to earn a return on your investment in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds of this offering of shares of our common stock, after deducting our offering expenses, for general corporate
purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot specify with certainty all of the particular uses of the net proceeds that we will receive from this offering and
have not quantified or allocated any specific portion of the net proceeds or range of net proceeds to any particular purpose. Accordingly, we will have broad discretion in using these proceeds. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_6"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our net tangible book value as of September&nbsp;30, 2023, was approximately $31,583,000, or $1.55 per share. Net tangible book value per
share is determined by dividing our total tangible assets, less total liabilities, by the number of our common shares outstanding as of September&nbsp;30, 2023. Dilution with respect to net tangible book value per share represents the difference
between the amount per share paid by purchasers of our common shares in this offering and the net tangible book value per common share immediately after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After giving effect to the sale of 928,571 shares of our common stock with an aggregate offering price of $32,500,000 at an offering price of
$35.00 per share, and after deducting estimated offering expenses of $240,000 payable by us, our as adjusted net tangible book value as of September&nbsp;30, 2023, would have been approximately $63,843,000, or $3.00 per share. This represents an
immediate increase in net tangible book value of $1.45 per share to existing shareholders and immediate dilution of $32.00 per share to investors purchasing shares of our common stock in this offering at the offering price. The following table
illustrates this dilution on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net tangible book value per share of as September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As adjusted net tangible book value per share as of September&nbsp;30, 2023, after giving effect
to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 3.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to investors purchasing our common shares in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above discussion and table are based on 20,356,000 shares outstanding as of September&nbsp;30, 2023, and
excludes an aggregate of 675,000 shares of our common stock issuable pursuant to outstanding stock awards and 1,444,000 shares reserved for future issuance under our equity incentive plans as of September&nbsp;30, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that equity awards outstanding as of September&nbsp;30, 2023, have been or may be exercised, an investor purchasing shares of
our common stock in this offering may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future
operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_7"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are selling 928,571 shares of our common stock directly to specified purchasers. We have entered into Common Stock Purchase Agreements,
each dated as of February&nbsp;24, 2024, with such purchasers relating to the sale of these shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the
terms and conditions of the Common Stock Purchase Agreements, on the closing date, we will issue shares of our common stock to such purchasers, and we will receive gross proceeds in the amount of $32,500,000. We estimate that the expenses of this
offering payable by us will be approximately $240,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common shares were offered directly to the purchasers without a placement
agent, underwriter, broker or dealer. We currently anticipate that the closing of the sale of such common shares will take place on or about February&nbsp;27, 2024. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_8"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the issuance of the securities offered hereby will be passed upon for us by Perkins Coie LLP, Portland, Oregon. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_9"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Digimarc Corporation as of December 31, 2022 and 2021, and for each of the years in the <FONT
STYLE="white-space:nowrap">two-year</FONT> period ended December 31, 2022, have been incorporated by reference herein in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon
the authority of said firm as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_10"></A>WHERE YOU CAN FIND MORE INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement to register the securities offered by this prospectus supplement under the
Securities Act. This prospectus supplement is part of that registration statement, but omits some information contained in the registration statement, as permitted by SEC rules. For further information with respect to Digimarc and this offering,
reference is made to the registration statement and the exhibits and any schedules filed with the registration statement. Statements contained in this prospectus supplement as to the contents of any document referred to are not necessarily complete
and in each instance, if the document is filed as an exhibit, reference is made to the copy of the document filed as an exhibit to the registration statement, each statement being qualified in all respects by that reference. You may obtain copies of
the registration statement, including exhibits, as noted in the paragraph below or by writing or telephoning us at: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Digimarc Corporation
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8500 SW Creekside Place </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Beaverton, Oregon 97008 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(503)
469-4800 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and other reports, proxy statements and other information with the
SEC. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. The address of that site is <I>http://www.sec.gov</I>. Our
Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q,</FONT> and Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> including any
amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act may also be accessed free of charge by linking directly from the &#147;Investors&#148; page of our
website at <I>www.digimarc.com/investors</I>. These filings will be available as soon as reasonably practicable after we electronically file this material with, or furnish it to, the SEC. Information contained on our website is not part of this
prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc774116_11"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate information into this prospectus supplement by reference, which means that we disclose important information to you by
referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus supplement, except for any such information superseded by information contained in later-filed
documents or directly in this prospectus supplement. This prospectus supplement incorporates by reference the documents set forth below that we have previously filed with the SEC (excluding those portions of any Form
<FONT STYLE="white-space:nowrap">8-K</FONT> that are not deemed &#147;filed&#148; pursuant to the General Instructions of Form 8-K). These documents contain important information about us and our financial condition. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000143774923005216/dmrc20221231_10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on March&nbsp;2, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000143774923013925/dmrc20230331_10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended March&nbsp;31, 2023, filed with the SEC on May&nbsp;11, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923022530/dmrc20230630_10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended June&nbsp;30, 2023, filed with the SEC on August&nbsp;8, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923030685/dmrc20230930_10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended September&nbsp;30, 2023, filed with the SEC on November&nbsp;7, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000119312523041167/d435982d8k.htm">February&nbsp;16,
 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000119312523073122/d439959d8k.htm">March&nbsp;
17, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923014223/dmrc20230502_8k.htm">May&nbsp;
12, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923015726/dmrc20230522_8ka.htm">May&nbsp;
24, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000119312523161243/d516354d8k.htm">June&nbsp;
6, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000119312524004808/d862282d8k.htm">January<U></U>&nbsp;9, 2024</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The portions of our <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000143774923008239/dmrc20230321_def14a.htm">Definitive
 Proxy Statement on Schedule 14A</A>, filed on March&nbsp;28, 2023, that are deemed &#147;filed&#148; with the SEC under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000110465908064430/a08-26252_18a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A> filed with the SEC on October&nbsp;16, 2008; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our capital stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908007643/a2186538z10-12b.htm">Form
 10</A> filed with the SEC on June&nbsp;23, 2008, and <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908008301/a2186908z10-12ba.htm">Amendment No.&nbsp;1</A> thereto, filed with the SEC on July&nbsp;
22, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908009252/a2186908z10-12ba.htm">Amendment No.&nbsp;2</A> thereto, filed with the SEC on August&nbsp;
13, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908009940/a2186908z10-12ba.htm">Amendment No.&nbsp;3</A> thereto, filed with the SEC on September&nbsp;
9, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010564/a2186908z10-12ba.htm">Amendment No.&nbsp;4</A> thereto, filed with the SEC on October&nbsp;
2, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010750/a2186908z10-12ba.htm">Amendment No.&nbsp;5</A> thereto, filed with the SEC on October&nbsp;
7, 2008; and <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010841/a2186908z10-12ba.htm">Amendment No.&nbsp;6</A> thereto, filed with the SEC on October&nbsp;14, 2008. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
termination of this offering, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus supplement and deemed to be part of this prospectus supplement from the date of
the filing of the reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide at no cost to each person, including any beneficial owner, to whom this
prospectus is delivered, upon written or oral request, a copy of any or all documents that are incorporated by reference into this prospectus, but not delivered with the prospectus, other than exhibits to the documents unless the exhibits are
specifically incorporated by reference into the documents that this prospectus incorporates. You should direct written requests to: Digimarc Corporation, 8500 SW Creekside Place, Beaverton, Oregon, 97008; Attention: Charles Beck, Chief Financial
Officer, or you may call us at (503) <FONT STYLE="white-space:nowrap">469-4800.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information incorporated by reference is an
important part of this prospectus supplement. You should rely only upon the information provided in this prospectus supplement and accompanying prospectus and the information incorporated into this prospectus supplement and accompanying prospectus
by reference. We have not authorized anyone to provide you with different information. You should not assume that the information in this prospectus supplement or accompanying prospectus is accurate as of any date other than the date on the front
covers of these documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DIGIMARC CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$100,000,000 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common
Stock, Preferred Stock, Warrants, Debt Securities </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus provides a
general description of the securities we may offer from time to time and the general manner in which they may be offered. The specific terms of any securities to be offered, and any other information relating to a specific offering including the
specific manner in which the securities may be offered, will be set forth in one or more supplements to this prospectus. You should read this prospectus and the related prospectus supplement carefully before you invest in our securities. No person
may use this prospectus to offer and sell our securities unless a prospectus supplement accompanies this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the
Nasdaq Global Market under the symbol &#147;DMRC.&#148; The last reported sale price of our common stock on the Nasdaq Global Market on June 22, 2023, was $28.23 per share. We will provide information in any applicable prospectus supplement
regarding any listing of securities other than shares of our common stock on any securities exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell securities directly to
investors, through agents designated from time to time or to or through underwriters or dealers. For additional information on the methods of sale, you should refer to the section entitled &#147;Plan of Distribution&#148; in this prospectus. If any
underwriters are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of the underwriters and any applicable commissions or discounts will be set forth in a prospectus supplement. The price to
the public of the securities and the net proceeds we expect to receive from the sale will also be set forth in a prospectus supplement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Investing in
our securities involves risks. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>See &#147; <A HREF="#toc774116_3">Risk Factors</A> &#148; on page 3 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is
July&nbsp;19, 2023. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_2">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_6">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_7">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_8">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_9">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc774116_14">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement we have filed with the Securities and Exchange Commission (&#147;SEC&#148;) using a &#147;shelf&#148;
registration process. Using this process, we may from time to time offer and sell the securities described in this prospectus in one or more offerings. This prospectus provides you with a general description of the securities we may offer. Each time
we use this prospectus to offer securities, we will file a supplement to this prospectus with the SEC that will describe the specific terms of the offering and the manner in which the securities will be offered, including the specific amounts,
prices and terms of the securities offered. The prospectus supplement may also add to, update or change the information contained in this prospectus and, accordingly, to the extent inconsistent, information in this prospectus will be superseded by
the information in the prospectus supplement. Before you invest, you should carefully read this prospectus, the applicable prospectus supplement and the information contained in the documents we refer to under the headings &#147;Where You Can Find
More Information&#148; and &#147;Incorporation of Certain Information by Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained or
incorporated by reference in this prospectus and any accompanying prospectus supplement. We have not authorized anyone to provide you with additional or different information. The prospectus may be used only for the purposes for which it has been
published. If you receive any other information, you should not rely on it. You should assume that the information contained in this prospectus or any accompanying prospectus supplement is accurate only as of the date on the front cover of the
applicable document. Our business, financial condition, results of operations or prospects may have changed since that date. You should not rely on or assume the accuracy of any representation or warranty in any agreement that we have filed as an
exhibit to the registration statement of which this prospectus is a part or that we may otherwise publicly file in the future because any such representation or warranty may be subject to exceptions and qualifications contained in separate
disclosure schedules, may represent the parties&#146; risk allocation in the particular transaction, may be qualified by materiality standards that differ from what may be viewed as material for securities law purposes or may no longer continue to
be true as of any given date. No offer of these securities is being made in any jurisdiction where such offer or sale is prohibited. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_2"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Digimarc Corporation (&#147;Digimarc,&#148; &#147;we&#148;, &#147;our,&#148; and &#147;us&#148;) is a global leader in product digitization,
delivering business value across industries through unique identities&nbsp;and cloud-based solutions. Our technology highlights&nbsp;a product&#146;s journey to provide greater visibility into all relevant product data, allowing companies to make
more intelligent business decisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Digimarc Illuminate Platform is a distinctive software as a service platform that combines
Digimarc&#146;s digital watermarks and/or Quick Response (&#147;QR&#148;) codes with product cloud technologies. By digitizing products using our unique digital watermarks, QR codes, and/or other digital tags, products can connect with the web and
interact with consumers and digital devices. Interactions are powered by our product&nbsp;cloud, where&nbsp;data and instructions are provided based on context, and which captures a record of every interaction.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Digimarc&nbsp;product suite is built on top of the Digimarc Illuminate Platform to address specific business needs. All our products are
complementary to each other, providing&nbsp;exponential benefits when combined. By enabling customers to create digital identities for physical and digital media objects, Digimarc&#146;s technologies provide many benefits, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Digimarc Validate</B> protects product authenticity to ensure real products are in the right place. Our
technology delivers exclusive, covert digital watermarks and/or QR codes and a cloud-based record of product authentication information. In addition, consumer engagement capabilities provide a direct digital communications channel with consumers.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Digimarc Engage</B> unlocks an interactive communications channel connecting brands and consumers. Our
technology activates products and media through <FONT STYLE="white-space:nowrap">on-package</FONT> QR codes, enabling consumers to scan for more information. Combined with cloud-based rules, brands can deliver contextually relevant content based on
time, location, and more. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Digimarc Recycle</B> increases the recyclability of products and packaging through unique digital watermarks.
Our technology activates products and packaging with unique digital watermarks to improve accuracy and performance in recycling facilities. In addition, consumer engagement capabilities deliver a direct digital communications channel with consumers,
and a cloud-based record of recycling information provides new insights. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Digimarc Retail Experience</B> helps brands meet the evolving needs of retail partners and consumers. Our
technology leverages covert digital watermarks to provide an easier, frictionless shopping experience. In addition, consumer engagement capabilities deliver a direct digital communication channel with consumers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Digimarc has maintained a relationship with a consortium of central banks for over 24 years, providing trusted technology to help deter digital counterfeiting
of currency. The relationship was the first commercially successful large-scale use of our technologies and protects billions of banknotes in circulation globally.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Digimarc Corporation was incorporated in Delaware in 2008 and became an Oregon corporation in 2010. Our principal offices are located at 8500 SW Creekside
Place, Beaverton, Oregon 97008; our telephone number is (503) <FONT STYLE="white-space:nowrap">469-4800.</FONT> Our website address is www.digimarc.com. Information on our website or available by hyperlink from our website does not constitute part
of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An investment in our securities involves a high degree of risk. The prospectus supplement applicable to each offering of our securities may contain a
discussion of additional risks applicable to the offering. Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the heading &#147;Risk Factors&#148; in the applicable
prospectus supplement, together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and
assumptions discussed under Part I, Item 1A, &#147;Risk Factors,&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2022, as updated by our quarterly report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023, which are incorporated herein by reference, and may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future and
any prospectus supplement related to a particular offering. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also
affect our operations. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_4"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and documents incorporated herein by reference include &#147;forward-looking statements&#148; within the meaning of Section&nbsp;21E of the
Securities Exchange Act of 1934 and Section&nbsp;27A of the Securities Act of 1933 (the &#147;Securities Act&#148;). Words such as &#147;may,&#148; &#147;plan,&#148; &#147;should,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;anticipate,&#148;
&#147;intend,&#148; &#147;believe,&#148; &#147;project,&#148; &#147;forecast,&#148; &#147;estimate,&#148; &#147;continue,&#148;&nbsp;variations of such terms or similar expressions are intended to identify such forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, or other statements made by us, are made based on our expectations and beliefs concerning future events affecting us, and are subject to uncertainties
and factors (including those specified below) that are difficult to predict and, in many instances, are beyond our control. As a result, our actual results could differ materially from those expressed in or implied by any forward-looking statements,
and investors are cautioned not to place undue reliance on these statements. Forward-looking statements include, but are not limited to, statements relating to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the acquisition of EVRYTHNG and its impact on our business, including our expectations
regarding no additional shares being issued in connection with the acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the concentration of most of our revenue among few customers and the trends and sources of future revenue;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated successful advocacy of our technology by our partners; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our belief regarding the global deployment of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding potential outcomes of participating in the HolyGrail 2.0 initiative and the utility of our
products in the recycling industry; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ESG projects and ESG Impact Report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future level of investment in our business, including investment in research, development and engineering of
products and technology, development of our intellectual property, sales growth initiatives and development of new market opportunities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated expenses, costs, margins, provision for income taxes and investment activities in the foreseeable
future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our assumptions and expectations related to stock awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our belief that we have one of the world&#146;s most extensive patent portfolios in digital watermarking and
related fields; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated effect of our adoption of accounting pronouncements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding our critical accounting policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the impact of accounting pronouncements issued but not yet adopted;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated revenue to be generated from current contracts, renewals, and as a result of new programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates, judgments and assumptions related to impairment testing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variability of contracted arrangements in response to changes in circumstances underlying the original
contractual arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business opportunities that could require that we seek additional financing and our ability to do so;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth of our markets and our assumptions and beliefs related to those markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the existence of international growth opportunities and our future investment in such opportunities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected short-term and long-term liquidity positions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our capital expenditure and working capital requirements and our ability to fund our capital expenditure and
working capital needs through cash flow from operations or financing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our ability to meet future financial obligations as they become due within the coming
fiscal year; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of computerized trading on our stock price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capital market conditions, our expectations regarding credit risk exposure, interest rate volatility and other
limitations on the availability of capital, which could have an impact on our cost of capital and our ability to access the capital markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use of cash, cash equivalents and marketable securities in upcoming quarters and the possibility that our
deposits of cash and cash equivalents with major banks and financial institutions may exceed insured limits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strength of our competitive position and our ability to innovate and enhance our competitive differentiation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to our existing facilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">protection, development and monetization of our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to our relationship with our employees and the effect of increasing diversity within our
workforce; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs regarding cybersecurity incidents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to certain provisions in our bylaws and articles of incorporation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our beliefs related to legal proceedings and claims arising in the ordinary course of business.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that the risk factors specified above and the risk factors identified in Part I, Item 1A of our 2022 Annual Report, as
updated by our quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023, could affect our future performance and the liquidity and value of our securities and cause our actual results to differ
materially from those expressed or implied by forward-looking statements made by us or on our behalf. Investors should understand that it is not possible to predict or identify all risk factors and that there may be other factors that may cause our
actual results to differ materially from the forward-looking statements. All forward-looking statements made by us or by persons acting on our behalf apply only as of the date of this prospectus. We do not undertake any obligation to publicly update
or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of the filing of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise set forth in a prospectus supplement, we intend to use the net proceeds of any offering of securities for working capital and other general
corporate purposes, which may include the financing of capital expenditures, future acquisitions or share repurchases. We will have significant discretion in the use of any net proceeds. The net proceeds may be invested temporarily in
interest-bearing accounts and short-term interest-bearing securities until they are used for their stated purpose. We may provide additional information on the use of the net proceeds from the sale of the offered securities in an applicable
prospectus supplement relating to the offered securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_6"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If required, we will set forth in a prospectus supplement the following information regarding any material dilution of the equity interests of investors
purchasing securities in an offering under this prospectus: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the net tangible book value per share of our equity securities before and after the offering;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of the increase in such net tangible book value per share attributable to the cash payments made by
investors in the offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of the immediate dilution from the public offering price which will be absorbed by such investors.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_7"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description of our capital stock is a summary and is qualified in its entirety by the provisions of our articles of incorporation, bylaws and
applicable law. Copies of our articles of incorporation and bylaws have been filed as exhibits to the registration statement of which this prospectus forms a part. See &#147; <A HREF="#toc774116_13">Where You Can Find More Information</A>.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 50,000,000 shares of common stock, $0.001 par value per share; 10,000 shares of Series A Redeemable Nonvoting
Preferred Stock, par value $0.001 per share (&#147;Series A Preferred Stock&#148;); 500,000 shares of Series R Participating Cumulative Preferred Stock, par value $0.001 per share (&#147;Series R Preferred Stock&#148;); and 1,990,000 shares of
undesignated preferred stock, par value $0.001 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of May&nbsp;31, 2023, there were 20,325,681 shares of our common stock outstanding. Shares of our common stock are currently registered pursuant to
Section&nbsp;12 of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), and are listed on the Nasdaq Global Market under the symbol &#147;DMRC.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of our shareholders, including the
election of directors. Subject to preferences that may be granted to any then outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends as may be declared by our board of directors out of funds legally
available for such purpose, as well as any distributions to our shareholders. In the event of our liquidation, dissolution or winding up, holders of common stock are entitled to share ratably in all of our assets remaining after payment of
liabilities and the liquidation preference of any then outstanding preferred stock. Holders of common stock have no preemptive or other subscription or conversion rights. There are no redemption or sinking fund provisions applicable to the common
stock. All outstanding shares of common stock are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of May&nbsp;31, 2023, there were 10,000 shares of our Series A Preferred Stock issued and outstanding, and no shares of our Series B Convertible Preferred
Stock, par value $0.001 per share (&#147;Series B Preferred Stock&#148;) or Series R Preferred Stock issued or outstanding. There are currently no shares of preferred stock designated as Series B Preferred Stock. Our board of directors is
authorized, without further action by our shareholders, to designate and issue up to an additional 1,990,000 shares of our preferred stock in one or more series.<B> </B>Our board of directors may determine the designation, relative rights,
preferences and limitations of the shares of each series of preferred stock, among other features, and may modify the rights of the holders of our Series A Preferred Stock. The rights of the holders of our Series B Preferred Stock may only be
modified by the affirmative vote of the holders of a majority of the outstanding shares of that series, and the rights of holders of our Series R Preferred Stock may only be modified by the affirmative vote of the holders of <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of that series, voting as a separate class. Our Series B Preferred Stock ranks senior to our Common Stock, Series A Preferred Stock and Series R Preferred Stock with respect to
dividends and distributions on liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> and dissolution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of shares of our Series A Preferred Stock are not entitled to the payment of a dividend. As previously designated, holders of our Series B Preferred
Stock are entitled to dividends on an amount equal to $1,000 per share, plus all accumulated dividends (the &#147;Liquidation Preference&#148;) at the rate of 7.5% per annum, payable in cash or, at the option of the Company, accumulated and added to
the Liquidation Preference. As previously designated, holders of our Series B Preferred Stock are also entitled to participate in dividends declared or paid on our Common Stock and in offers to repurchase or exchange the Common Stock, in each case,
on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis. Holders of our Series R Preferred Stock are entitled to the payment of a dividend when, as, and if declared by our board of directors on a quarterly basis or whenever
our board of directors otherwise declares a dividend or distribution on our common stock (unless the dividend or distribution is solely in shares of our common stock) in an amount equal to the greater of (a) $0.001 and (b) 100 times the amount of
cash dividends then to be paid on each share of common stock (which is subject to adjustment under a formula set forth in our articles of incorporation). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Redemption </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may redeem shares of our Series A
Preferred Stock by paying holders of shares of our Series A Preferred Stock an amount equal to $5.00 per share. We may not redeem shares of our Series B Preferred stock, as previously designated, except for certain circumstances related to a change
of control of the Company, in which case we are required to redeem all of our then-outstanding shares of Series B Preferred Stock for cash consideration equal to the greater of (i)&nbsp;the Liquidation Preference, plus accrued and unpaid dividends
and (ii)&nbsp;the amount that such Holder would have been entitled to receive at such time if the Series B Preferred Stock were converted into Common Stock immediately prior to such change of control. We may not redeem shares of our Series R
Preferred Stock, but we are permitted to acquire shares of our Series R Preferred Stock in the open market or by offer to any holder of shares of Series R Preferred Stock. Moreover, if any dividends or distributions payable on our Series R Preferred
Stock are in arrears, we may not redeem, purchase or acquire for consideration (a)&nbsp;shares of our capital stock ranking junior to our Series R Preferred Stock, or (b)&nbsp;shares of our Series R Preferred Stock (or shares of a class ranking on a
parity with our Series R Preferred Stock), unless we acquire the shares by a public offer to purchase the shares of Series R Preferred Stock and shares on parity with these shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of our Series A Preferred Stock do
not have voting rights. As previously designated, holders of our Series B Preferred Stock vote together with holders of our Common Stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, applying a voting conversion price of $17.01
(subject to customary anti-dilution adjustments in the event of any stock split, stock dividend or distribution, or stock combination). Holders of our Series R Preferred Stock vote together with holders of our
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock and are entitled to a number of votes per share that is equal to 100 times the maximum number of votes to which any holder of shares of our common stock is entitled. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we undergo a voluntary or
involuntary liquidation, dissolution, distribution of assets or other winding up, holders of our Series A Preferred Stock will be entitled to payment of an amount equal to $5.00 per share of Series A Preferred Stock, subject to the rights of holders
of series of stock ranking senior to the Series A Preferred Stock. Under the same circumstances, holders of our Series B Preferred Stock, as previously designated, will be entitled to receive an amount per share equal to the greater of (i)&nbsp;the
Liquidation Preference, plus accrued and unpaid dividends and (ii)&nbsp;the amount that the holders of Series B Preferred Stock would have been entitled to receive at such time if the Series B Preferred Stock were converted into Common Stock. Under
the same circumstances, holders of our Series R Preferred Stock are entitled to payment of an amount equal to the greater of (a) $0.001 per share and (b)&nbsp;the amount of any accrued but unpaid dividends and distributions plus the amount equal to
100&nbsp;times the aggregate amount per share to be distributed to holders of our common stock. The rights of holders of our Series R Preferred Stock to receive this payment rank junior to the rights of holders of other shares of our preferred
stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Oregon Control Share Act and Oregon Business Combination Act </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to provisions of Oregon law that may restrict the ability of our significant shareholders to exercise voting rights. The Oregon Control Share
Act generally applies to a person who acquires voting stock of an Oregon corporation in a transaction that results in that person holding more than <FONT STYLE="white-space:nowrap">one-fifth,</FONT> <FONT STYLE="white-space:nowrap">one-third</FONT>
or <FONT STYLE="white-space:nowrap">one-half</FONT> of the total voting power of the voting shares of the corporation. If such a transaction occurs, the person cannot vote the shares acquired in the acquisition unless voting rights are restored to
those shares by a vote of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of a majority of the outstanding voting shares of each voting group entitled to vote; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of a majority of the outstanding voting shares, excluding the acquired shares and shares held by the
corporation&#146;s officers and inside directors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The restricted shareholder may, but is not required to, submit to the corporation a
statement setting forth information about itself and its plans with respect to the corporation. The statement may request that the corporation call a special meeting of shareholders to determine whether voting rights will be granted to the shares
acquired. If a special meeting of shareholders is not requested, the issue of voting rights of the acquired shares will be considered at the next annual or special meeting of shareholders that is held more than 60 days after the date the shares are
acquired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also subject to provisions of Oregon law that govern business combinations between corporations and interested shareholders (the
&#147;Oregon Business Combination Act&#148;). The Oregon Business Combination Act generally prohibits a corporation from entering into a business combination transaction with a person, or an affiliate of that person, for a period of three years
following the date the person acquires 15% or more of the outstanding voting stock of the corporation. For the purposes of this law, the prohibition generally applies to the following business combination transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a merger or plan of share exchange, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the aggregate market
value of all of the assets of the corporation or the aggregate market value of all the outstanding stock of the corporation, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions that result in the issuance or transfer of capital stock of the corporation to the 15% shareholder.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, the general prohibition does not apply if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the 15% shareholder, as a result of the transaction in which the person became a 15% shareholder, owns at least
85% of the voting stock of the corporation outstanding at the time the transaction commenced (excluding shares owned by directors who are also officers, and certain employee benefit plans), </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors approves either (i)&nbsp;the business combination or (ii)&nbsp;the transaction that
resulted in the person becoming an interested shareholder before the transaction by which the shareholder acquires 15% or more of the corporation&#146;s outstanding voting stock occurs, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors and the holders of at least 66 2/3% of the outstanding voting stock of the corporation,
excluding shares owned by the 15% shareholder, approve the transaction at an annual or special meeting on or after the date the shareholder acquires 15% or more of the corporation&#146;s voting stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_8"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue warrants for the purchase of debt securities, preferred stock, or common stock. Each series of warrants will be issued under a separate warrant
agreement to be entered into between us and a bank or trust company, as warrant agent. The warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with
any registered holders of warrants or beneficial owners of warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will distribute a prospectus supplement with regard to each issue of warrants.
Each prospectus supplement will describe: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of warrants to purchase debt securities, the designation, aggregate principal amount, currencies,
denominations and terms of the series of debt securities purchasable upon exercise of the warrants and the price at which you may purchase the debt securities upon exercise; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of warrants to purchase preferred stock, the designation, number of shares, stated value and terms,
such as liquidation, dividend, conversion and voting rights, of the series of preferred stock purchasable upon exercise of the warrants and the price at which you may purchase that number of shares of preferred stock of the series upon exercise;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of warrants to purchase common stock, the number of shares of common stock purchasable upon the
exercise of the warrants and the price at which you may purchase that number of shares of common stock upon exercise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period during which you may exercise the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provision adjusting the securities that may be purchased on exercise of the warrants, and the exercise price
of the warrants, to prevent dilution or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of warrants or rights outstanding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where warrants can be presented for exercise or for registration of transfer or exchange; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms of the warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warrants for the purchase of preferred stock and common stock will be offered and exercisable for U.S. dollars only. Warrants will be issued in registered
form only. The exercise price for warrants will be subject to adjustment as described in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the exercise of any warrants to purchase debt securities, preferred stock or common stock, holders
of the warrants will not have any of the rights of holders of the debt securities, preferred stock or common stock purchasable upon exercise, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of warrants for the purchase of debt securities, the right to receive payments of principal of, any
premium or interest on the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of warrants for the purchase of preferred stock or common stock, the right to vote or to receive any
payments of dividends or preferences on the preferred stock or common stock purchasable upon exercise. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_9">
</A>DESCRIPTION OF DEBT SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this prospectus, debt securities means the debentures, notes, bonds and other evidences of indebtedness
that we may issue from time to time. The debt securities will either be senior debt securities or subordinated debt securities. We may also issue convertible debt securities. Senior debt securities will be issued under a &#147;Senior Indenture&#148;
and subordinated debt securities will be issued under a &#147;Subordinated Indenture,&#148; each entered into between us and a trustee to be named in the Indenture. This prospectus sometimes refers to the Senior Indenture and the Subordinated
Indenture collectively as the &#147;Indentures.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indentures or forms of Indentures will be filed as exhibits to the registration statement of
which this prospectus is a part. The statements and descriptions in this prospectus or in any prospectus supplement regarding provisions of the Indentures and debt securities are summaries thereof, do not purport to be complete and are subject to,
and are qualified in their entirety by reference to, all of the provisions of the Indentures (and any amendments or supplements we may enter into from time to time that are permitted under each Indenture) and the debt securities, including the
definitions in the applicable Indenture of various terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in a prospectus supplement, the debt securities will be direct
unsecured obligations of Digimarc. The senior debt securities will rank equally with any of our other unsecured senior and unsubordinated debt. The subordinated debt securities will be subordinate and junior in right of payment to any senior
indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indentures do not limit the aggregate principal amount of debt securities that we may issue and provide that we may issue debt
securities from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. Unless indicated in a prospectus supplement, we may issue additional debt securities of a particular series without the
consent of the holders of the debt securities of the series outstanding at the time of the issuance. Any of the additional debt securities, together with all other outstanding debt securities of that series, will constitute a single series of debt
securities under the applicable Indenture and will be equal in ranking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The senior indebtedness issued pursuant to the Senior Indenture will effectively
be subordinate to any of our secured indebtedness. In the event of a bankruptcy or other liquidation event involving a distribution of assets to satisfy our outstanding indebtedness, or an event of default under a loan agreement relating to secured
indebtedness, the holders of our secured indebtedness would be entitled to receive payment of principal and interest prior to payments on the senior indebtedness issued under the Senior Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the senior indebtedness issued pursuant to the Senior Indenture will effectively be subordinate to any indebtedness of any subsidiaries. In the
event of a bankruptcy, receivership, state-ordered rehabilitation, liquidation or similar event involving a subsidiary, the assets of that subsidiary would be used to satisfy claims of creditors of the subsidiary rather than our creditors. As a
result of the application of the subsidiary&#146;s assets to satisfy claims of creditors, the value of the stock of the subsidiary would be diminished and perhaps rendered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
worthless. Any diminution in the value of the shares of any subsidiaries would adversely affect our financial condition and possibly impair our ability to meet our obligations on the debt
securities. In addition, any liquidation of the assets of any subsidiaries to satisfy claims of the subsidiary&#146;s creditors might make it impossible for the subsidiary to pay dividends to us. This inability to pay dividends would further impair
our ability to satisfy our obligations under the debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each prospectus supplement will describe the terms relating to the specific series of debt securities being offered. These terms will include some or all of
the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the series of the offered debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices at which the offered debt securities will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the offered debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal of the offered debt securities will be payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) per year at which the offered debt securities will bear
interest, if any, or the method of determining the rate or rates and the date or dates from which interest, if any, will accrue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the amount of principal, premium or interest with respect to the offered debt securities of the series may be
determined with reference to an index or pursuant to a formula, the manner in which these amounts will be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which interest, if any, on the offered debt securities will be payable and the regular
record dates for the payment thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places, if any, in addition to or instead of the corporate trust office of the trustee, where the
principal, premium and interest with respect to the offered debt securities will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period or periods, if any, within which, the price or prices of which, and the terms and conditions upon
which the offered debt securities may be redeemed, in whole or in part, pursuant to optional redemption provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms on which we would be required to redeem or purchase the offered debt securities pursuant to any sinking
fund or similar provision, and the period or periods within which, the price or prices at which and the terms and conditions on which the offered debt securities will be so redeemed and purchased in whole or in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the offered debt securities will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the form of the offered debt securities and whether the offered debt securities are to be issued in whole or in
part in the form of one or more global securities and, if so, the identity of the depositary for the global security or securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of the principal amount of the offered debt securities that is payable on the declaration of
acceleration of the maturity, if other than their principal amount; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than U.S. dollars, the currency or currencies in which the offered debt securities will be denominated
and payable, and the holders&#146; rights, if any, to elect payment in a foreign currency or a foreign currency unit other than that in which the offered debt securities are otherwise payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the offered debt securities will be issued with guarantees and, if so, the terms of any guarantee of the
payment of principal and interest with respect to the offered debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the general type of event that constitutes a default and any addition to, or modification or deletion of, any
event of default or any covenant specified in the indenture; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the offered debt securities will be convertible or exchangeable into other securities, and if so, the
terms and conditions upon which the offered debt securities will be convertible or exchangeable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the offered debt securities will be senior or subordinated debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any trustees, authenticating or paying agents, transfer agents or registrars or other agents with respect to the
offered debt securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other specific terms of the offered debt securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange and will be issued in
fully-registered form without coupons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of the debt securities may present their securities for exchange and may present registered debt
securities for transfer in the manner described in the applicable prospectus supplement. Except as limited by the applicable Indenture, we will provide these services without charge, other than any tax or other governmental charge payable in
connection with the exchange or transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Debt securities may bear interest at a fixed rate or a variable rate as specified in the prospectus supplement.
In addition, if specified in the prospectus supplement, we may sell debt securities bearing no interest or interest at a rate that at the time of issuance is below the prevailing market rate, or at a discount below their stated principal amount. We
will describe in the applicable prospectus supplement any special federal income tax considerations applicable to these discounted debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
may issue debt securities with the principal amount payable on any principal payment date, or the amount of interest payable on any interest payment date, to be determined by referring to one or more currency exchange rates, commodity prices, equity
indices or other factors. Holders of these debt securities may receive a principal amount on any principal payment date, or interest payments on any interest payment date, that are greater or less than the amount of principal or interest otherwise
payable on those dates, depending upon the value on those dates of applicable currency, commodity, equity index or other factors. The applicable prospectus supplement will contain information as to how we will determine the amount of principal or
interest payable on any date, as well as the currencies, commodities, equity indices or other factors to which the amount payable on that date relates and various additional tax considerations. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may distribute the securities from time to time in one or more transactions at a fixed price or prices, which may be changed, or at prices determined as
the prospectus supplement specifies. We may sell securities to one or more underwriters for public offering and sale by them or may sell securities to investors directly or through agents. We will name any underwriter or agent involved in the offer
and sale of securities in the prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters may offer and sell the securities at a fixed price or prices, which may be changed.
Underwriters may also offer and sell securities at market prices, at prices related to market prices or at negotiated prices. We also may authorize underwriters acting as our agents to offer and sell the securities upon the terms and conditions set
forth in any prospectus supplement. In connection with the sale of securities, we may be deemed to have paid compensation to the underwriters in the form of underwriting discounts or commissions. Underwriters may also receive commissions from
purchasers of securities for whom they may act as agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters may sell securities to or through dealers, and such dealers may receive
compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions (which may be changed from time to time) from the purchasers for whom they may act as agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying prospectus supplement will set forth the terms of the offering and the method of
distribution and will identify any firms acting as underwriters, dealers or agents in connection with the offering, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchase price of the securities and the proceeds to us from the sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any underwriting discounts and other items constituting underwriter compensation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any public offering price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any discounts or concessions allowed or reallowed or paid to dealers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any securities exchange on which the securities offered in the prospectus supplement may be listed.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Securities Act, underwriters, dealers and agents participating in the distribution of the securities may be deemed to be
underwriters, and any discounts and commissions they receive and any profit they realize on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements with underwriters, dealers and agents
providing them indemnification against and contribution toward specified civil liabilities, including liabilities under the Securities Act, and reimbursement for various expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will indicate the extent to which we anticipate that a secondary market for the securities will be available in the prospectus supplement. Our common stock
is listed on the Nasdaq Global Market. Except as indicated in the applicable prospectus supplement, securities other than common stock are not expected to be listed on any securities exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus may be amended or supplemented from time to time, if required, to describe a specific plan of distribution. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, the validity of the issuance of the securities offered hereby will be passed upon for us
by Perkins Coie LLP, Portland, Oregon. Any underwriters will be represented by their own legal counsel, which will be named in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_12"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
consolidated financial statements of Digimarc Corporation as of December&nbsp;31, 2022 and 2021, and for each of the years in the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended December&nbsp;31, 2022, have been incorporated by
reference herein in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement to register the securities offered by this prospectus under the Securities Act. This prospectus is part of
that registration statement, but omits some information contained in the registration statement, as permitted by SEC rules. For further information with respect to Digimarc and this offering, reference is made to the registration statement and the
exhibits and any schedules filed with the registration statement. Statements contained in this prospectus as to the contents of any document referred to are not necessarily complete and in each instance, if the document is filed as an exhibit,
reference is made to the copy of the document filed as an exhibit to the registration statement, each statement being qualified in all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respects by that reference. You may obtain copies of the registration statement, including exhibits, as noted in the paragraph below or by writing or telephoning us at: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Digimarc Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8500 SW
Creekside Place </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Beaverton, Oregon 97008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(503) <FONT STYLE="white-space:nowrap">469-4800</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and other reports, proxy statements and other information with the SEC. The SEC maintains an internet site that contains reports,
proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. The address of that site is <I>http://www.sec.gov</I>. Our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> including any amendments to those reports, and other
information that we file with or furnish to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act may also be accessed free of charge by linking directly from the &#147;Investors&#148; page of our website at
<I>www.digimarc.com/investors</I>. These filings will be available as soon as reasonably practicable after we electronically file this material with, or furnish it to, the SEC. Information contained on our website is not part of this prospectus.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc774116_14"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We incorporate information into this prospectus by reference, which means that we disclose important information to you by referring you to another document
filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, except for any such information superseded by information contained in later-filed documents or directly in this prospectus. This
prospectus incorporates by reference the documents set forth below that we have previously filed with the SEC (excluding those portions of any Form <FONT STYLE="white-space:nowrap">8-K</FONT> that are not deemed &#147;filed&#148; pursuant to the
General Instructions of Form <FONT STYLE="white-space:nowrap">8-K).</FONT> These documents contain important information about us and our financial condition. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000143774923005216/dmrc20221231_10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on March&nbsp;2, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000143774923013925/dmrc20230331_10q.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended March&nbsp;31, 2023, filed with the SEC on May&nbsp;11, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001438231/000119312523041167/d435982d8k.htm">February
 <U></U>16, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000119312523073122/d439959d8k.htm">March<U></U>&nbsp;
17, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923014223/dmrc20230502_8k.htm">May<U></U>&nbsp;
12, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000143774923015726/dmrc20230522_8ka.htm">May<U></U>&nbsp;
24, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1438231/000119312523161243/d516354d8k.htm">June<U></U>&nbsp;6, 2023</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The portions of our <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000143774923008239/dmrc20230321_def14a.htm">Definitive
 Proxy Statement on Schedule 14A</A>, filed on March&nbsp;28, 2023, that are deemed &#147;filed&#148; with the SEC under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000110465908064430/a08-26252_18a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A> filed with the SEC on October&nbsp;16, 2008; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our capital stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908007643/a2186538z10-12b.htm">Form
 10</A> filed with the SEC on June&nbsp;23, 2008, and <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908008301/a2186908z10-12ba.htm">Amendment No.&nbsp;1</A> thereto, filed with the SEC on July&nbsp;
22, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908009252/a2186908z10-12ba.htm">Amendment No.&nbsp;2</A> thereto, filed with the SEC on August&nbsp;
13, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908009940/a2186908z10-12ba.htm">Amendment No.&nbsp;3</A> thereto, filed with the SEC on September&nbsp;
9, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010564/a2186908z10-12ba.htm">Amendment No.<U></U>&nbsp;4</A> thereto, filed with the SEC on October&nbsp;
2, 2008; <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010750/a2186908z10-12ba.htm">Amendment No.&nbsp;5</A> thereto, filed with the SEC on October&nbsp;
7, 2008; and <A HREF="http://www.sec.gov/Archives/edgar/data/1438231/000104746908010841/a2186908z10-12ba.htm">Amendment No.&nbsp;6</A> thereto, filed with the SEC on October&nbsp;14, 2008. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of this
offering, including all the documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the
SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of the reports and documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>928,571&nbsp;Shares </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DIGIMARC CORPORATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g774116g45f56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>February&nbsp;26,&nbsp;2024 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g774116g45f56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g774116g45f56.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X54I:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 Y+C$M8S P,2 W.2XV
M-S5D,&8W+" R,#(S+S V+S$Q+3$Y.C(Q.C$V(" @(" @(" B/@H@(" \<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z
M>&UP1TEM9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(*
M(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @
M(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SII
M;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q
M+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS
M(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+V<O(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N
M<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \9&,Z9F]R;6%T/F%P
M<&QI8V%T:6]N+W!O<W1S8W)I<'0\+V1C.F9O<FUA=#X*(" @(" @(" @/&1C
M.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @
M/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CYD<W P,#$\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@
M(" @(" @(" \9&,Z9&5S8W)I<'1I;VX^"B @(" @(" @(" @(#QR9&8Z06QT
M/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^
M1FEL92!.86UE.B @(" @(" @(" @(" @(&1S<# P,2YA:28C>$$[57-E<FYA
M;64Z(" @(" @(" @(" @("!$96QT828C>$$[3&]C86P@5&EM93H@(" @(" @
M(" @(" @,C$M1F5B+3(P,C0@,3,Z,3,Z,#8F(WA!.T535"!4:6UE.B @(" @
M(" @(" @(" @,C$M1F5B+3(P,C0@,#,Z-#,Z,#8F(WA!.U-C<FEP="!697)S
M:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @
M,C@N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($%R='=O<FLF(WA!
M.R8C>$$[*BHJ5&AE('!R969L:6=H="!C:&5C:R!I<R!C;VUP;&5T92X@4&QE
M87-E(&5N<W5R92!M86YU86P@8VAE8VMS(&%R92!C;VUP;&5T960@<&5R('!R
M;V-E<W,N*BHJ)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R-"TP,BTR,50Q,SHQ,SHQ-RLP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$
M871E/C(P,C0M,#(M,C%4,3,Z,3,Z,3<K,#4Z,S \+WAM<#I-;V1I9GE$871E
M/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R-"TP,BTR,50Q,SHQ,SHQ
M-RLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O
M<E1O;VP^061O8F4@26QL=7-T<F%T;W(@,C@N," H5VEN9&]W<RD\+WAM<#I#
M<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @
M(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG
M.G=I9'1H/C(U-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z:&5I9VAT/C$U-CPO>&UP1TEM9SIH96EG:'0^"B @(" @(" @
M(" @(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA
M=#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3
M:UI*4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K
M;$Y!*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K
M1FMB,DIL04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G
M1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)1
M5$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F
M2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%N045!07=%4B8C>$$[
M04%)4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!
M44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"
M9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%6
M14=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z
M4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3
M,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B
M5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP
M95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$
M0E%514)1645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[
M;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G
M>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT
M3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W
M9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F
M:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y531Q-T98
M67$W1EA9<3=&6%EQ-R8C>$$[1EA9<3=&6%EQ-T9867$W1EA9<3=&6'@Q9&9M
M5#4O:G9*46YM0R]!4U)U23ED>4YM,C)*>G))-E1&6#!H-6EE<WEI4CE2-7!L
M<'8U-28C>$$[9FU863!(-E9&,4=$6&AC>%)35BMB8U9F+VAS<FXR9&AL,'!L
M1'1(34]T<S<X=CA!+T]48D8Q:CAW85%!<$DU6$9G>#(O=T-E37!.9B8C>$$[
M*U)M65=8<VHK669M-6U,=%EF>&HU4%=V3$AN<GER-6YI-39.<45D>$E">6MT
M:CA%-D0O2VIA:E4Y*VUA=DYP<#0O<41S.%=E1U%E:R8C>$$[,FXR54YZ<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER1R]-2#5J95-F3"8C>$$[-TY(<6UR=U)80U8U5WE%>E1!
M:G-9-&<W3#E)>DEX85A*4#91,%ID5&IH.5)9=D@K965N86I*-EAL>GDO<3)T
M35!T4$9#1FI(*WE"8R8C>$$[:C9137E4,F-9+UA+35=G8313*VE-<&9"34QF
M>G K6E9Y03A8:T8P:4DR830Q3S-H879H=TU:8DMZ<#A)+W=!<"]S4WI'8DME
M55!N228C>$$[4$-T4B]*4#AZ:VML=41O,W%+>D9Y27 W9'E/4G)4:4@U2#9"
M;39H,FAH-6-8,D8P,E1S+TY:3F9A>%16+TLO;5!2:E169$UU<DED;B8C>$$[
M;6ED15!B6FE/2BMG-6Q1>E%N.4I"8UA*9VY$-F=1;&57=%-T85AD,5HS161Z
M85108C-%4C52>E)-56133S9S=$--:DM)26]P:DEX3B8C>$$[:EEV9%!Y>B]!
M1"]E4U-,4V9/1&HT:45G,6-!2TLY04QH4G0O<W@Y4&IM;#%F6FXX5U U9G%D
M,7!/,'(Y3U0U+W)E-GAY2DEI>5)S2"8C>$$[4G='4C%.45%D=U%2;6Q)9'<S
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<D904%@U;"8C>$$[*U=V2C%T6%5*9E=V,T993D]H;UI8.$-E>4PO
M;$XY1F-Y=$YP2C54='DW,T@Q1W%H:4AQ*U1X>%!-=C5S9FUR9GDR96MS9$LP
M5E138R8C>$$[=W,P54M+93!S=TA/5FE0,E(Q+VQ'8EDT8T=M1GDY56Y6:DYN
M,4IQ4'!J*T]R,&)Y:BM22&MV43!382]I+U1/;T-H86$V1EE1,RM20B8C>$$[
M=710.69L;79Z.7!:2C=$,&IY8S=$,F9J:'5F569.-DY$1$9$17-52TQ(16<T
M<$=G0W%!3W=!,D=90DYU8S)Z2W%L;4E65D935'-!0B8C>$$[9U9$+T%+53!Z
M+VQR:"\U1THO6$IC174U1FA826EL:4E)5U-+4F%%1VI+>7-0=4E)=V-K<T(X
M,V9K:C5).'=).'-.<TY*=C(S1GI:9R8C>$$[2W!0*UA$<VIF4E$K*UIU1'1$
M2FHV.%$X,T1Z-DA(:S959DHX*RME+WEX.'DK5%IW8BM-5#9F23-'1%5986U*
M:C)6=39.-T@V2S5V9"8C>$$[3G))6E)T>C=N4C9N4GIX8SDT.3=%8WDS164P
M+VM6*V%K;&ID42M63F%M3%=%-4-A6&-/82MJ251T0U-F,DA0,F9!*W@R,"]A
M3VES8R8C>$$[8V5F5C(O6C)S;RM(3#1F<691*V%&,VIS5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F5D+VTU*R8C>$$[
M87-(:RMX1FI91EIV348R;%E%3S9W4FUO.5IX,S,K>79F-41F4#!/:4]5,F9P
M1&AA>E=$14M(,48T;"M8=FMB5W9Z1SAY,T8U<59X2R8C>$$[8DM.>$QQ;6]/
M874W361O:THR-70Y>6HV061X<7122%1W<4DS-D(Q1VPP.'1236U83'%8,4YP
M3VMA8G!';G<V9'!T=6QR6C(V.%EO628C>$$[>%%$,U!C:SEY9'IN3GIM6D=Y
M8DPP54E#26]C:UAK1U1S5E-J>FHO>6E/=68Y<RLV+W=#5$Q:8F<O=DDK.$U-
M;C!N,U!I8D]X95!F8B8C>$$[4&LW+T%*4DA1+SA!=&XR=B]*;&,T-U O04AK
M=F58<TUF,&HS2G9L5$Y1=C=#>C%#>FUS<C)&3&DP=49+5%%Y1&MR2V5X1U-J
M27A.:B8C>$$[;6E545)29DQ8-79F;&1,-5 Q25AL9W)395@W>&E,6GE3>E%V
M4W!H8VXO:$0S2'5--E11-GIX4E(K;U!/83=2*T5B:CE**W@U-$-1428C>$$[
M46%%8F=J33EW2#%Z*U5(;DHO3E!K>3)U8FPK97!76BMQ6'A*<7I01T)X:TYD
M+VI19VLK3F,U8EA94$-Y141K9'<Y5&\X+VE9=U1Z-B8C>$$[<S)Z1&-P,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+<%(U=3AY
M,F9L<GDW938Q9#=X,G-D56IR47E33B8C>$$[.$UA1"]766=:8F=X2$I-4DA6
M<GI:4D-*:V5J-#8Q2%5.6#AZ95E*3'4U6G)N53E4;D%!.%AK259%561G3FQ5
M9&AN5U%J2$A#:'E$>28C>$$[<S53>7IS.#5&.68K4U!+;&XU5CAT5V5J,G="
M849E5GI-4#A!9',W0W-J.75P-F4Q0FY+86I-8VMZ2795-$U)>'=%46YU571Q
M5F5A9B8C>$$[34YT-60X=E@R=%A+3DI&6E)M47A,<UA9:TMI,3=C;4E&8W1W
M-&IK;4EJ<3$U8V=H17E04C@P83$K9E@U:39H8TTY=F5P<'1U5%9,928C>$$[
M,FEJ;T(R<3AG9'HY.5!B3VAX.6TT;VIC5S@O:S=3>7E/>'!+8G(X,F9Z174W
M5V$Q=4YB;6MT-3!A2V%-<D92:V-&5T)O;F-(3%)O<R8C>$$[44YI3%=D9&U)
M<FDK-6E/6F)I4'1N>60O>6E/:"]W1&)0=&8K5$LU>#)F.$%V2F4X=EE9+W!(
M=51F2VUB<U93>GI,-65S4$U/:%AM:B8C>$$[,S9H<F4W:DMC<59+4#%34F8X
M<$=O=WEZ1&Q/3U%K3VI$2FI%-&U*-48X6&%X<%8S<$]Q,V5M6&DX8G%Y;&5#
M641C8VMA:$E09V4R9"8C>$$[9FIM2E)%:'E,>5=41UE3350P97)F.#0P-C Y
M=C5N,4A31V%K3CEB97-I.796=#)&2V8W0U)V=7I79')9-V=*9'AD;C)4:W%2
M:C-H.28C>$$[2%IZ-W9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ.$<O-7EA.'A0>3!N>3='>$,P82]U5C='<$U54"8C>$$[
M,U5K>F0Y:UEU8R]G-F)T8DQS269&9R\U1V%62'%(-6MA8UI">6IS,6QU>5!E
M3D-%4#!/>6Y->G1'9D1H4&YS-&Y:<T],2U!,9#E9-28C>$$[>D0P:G-6658K
M9$@O04I,2%AF.$%J2$8O>69J>DTP2#DY1GAD8B]D4SEZ-4QS9CA!93(S+T%/
M36EF.%-'9%),:UAM8U@Q1#-V=$QZ:B8C>$$[+W=!;VIR;B]!1WHW<B]K>3)C
M:&<O=DDK.%!7-5!P4'5F13)D:3AE*S)F2C,O2TDV2"\R>C=8+VMY=6-D;B]V
M2F4X=EE9+W!(=51F2R8C>$$[;6)S5F1I<C5F+S5Y23!M3WDO340V,4=!0G%.
M<$9C4%0K9%,P2B]#24A/:S=,;F5+=31V4&1Q47)*9F5%2"M18DU0>DXP-$%K
M0F]R:R8C>$$[165).4)Z:W4P+S=K+T)J,EHO92]".5=:>DPP8G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F9+9C4K,R8C>$$[
M5%1F;6)Q15I.4F)25S!3:G=":%=4+VU:;E1D;4-S23@W96(W5&QE62M10TTO
M=T-C9%IO-"]W07<K1%4U5%=5-DI8<E5&2#(Y-DEC:B8C>$$[,G%0,UAX6CEL
M9C-V=R]5*V]--70V1C)+<TLO3VHO>5=/=2\X631V*U0X95IM9R]V;W5,<F8W
M<5AU9DID:B]V8F(O.$%'4E K2D1/;R8C>$$[;'E,>D],-F@W,S)L-7@O-5)(
M6% K,F9D9CAM5WIK34@Y-4@S:#8S2CE*.7HT;7IS6&HS,GHU3R\U4DA1+W=$
M=&XR=B]!0UI83T]Z+R8C>$$[04XU3#-L-T1(.4DY>6(U57ID:7)S5F9/4"]/
M5%5Y2'I8<%5)035P66-Y93E(;6-$+VE">F8Y:T0P12MB;W4Q:C9O:GE1=CA!
M>FIF<"8C>$$[5#-0;F$U=GE$-E=N,F)N;"]W05=437%+4'!8;CDR5#=7;E=-
M1'9,2'-Q1C5#9310<&I/9&0K-T9867$W1EA9<3=&6%EQ-T9867$W1B8C>$$[
M6%EQ-T9867$W1EA9<3=&6%EQ-T98>70O>FM"6G9B+VU695-S=D588T9V36@X
M44EH1E@W-&E--F)S>58T4C57.#4R;D=S=G9$1V9Y*R8C>$$[.'=R-64X-394
M<7IK<D)"3T9U4U Y.'EG>'DO8VIK-6MA<D8T;4UX8V936F5$24,K>FQ:6%5/
M:$1+=T)69V%G9SE#1&Y)=E9T-'%W<B8C>$$[.#90+T%#5T]U+SA!1T],+T%*
M4'@U;6%$*RMI-'5T+W5P934X;#)0*SET=B]!35I%+W=#2D1/;VQY3'I/3#9H
M-S,R;#5X+S522%A0*R8C>$$[,F9D9CAM5WIK34@Y-4@S:#8S2CE*.7HT;7IS
M6&HS,GHU3R\U4DA1+RLR9F$O=T1*;&,T-U O95,Y-65W>"]34&-M*U9-,UEQ
M-T98>28C>$$[0BMB;FU/4%@O4#)P,V-,8W)71GAA,GI!,4)306-#=SEM8TUW
M*V5D6&]C6$)I05!0;3AV<CAV2&Q0;',Y,B])6'EI*VAE5$9V8FQ/1B8C>$$[
M-W),3&1/1'-6:$%P07 O,DI,+S=,3DHR;&XT.&Q$;$8S6%HK1&=X-S@U8G93
M8S$W;D]X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>"8C>$$[5C)+=7A6,DMU
M>%8R2W5X5C1F.$$X-4UE5VYL=$Y-.'AW<E@V=51:6%HX16,X-&HX9S--9E--
M,U!:1U=I669&,4AA=4LT:69C*V8X028C>$$[3C8V3CE++VM.*UDX3W-A4D@U
M83%'5416=$]4:F%&:G908DPY;6QE<E)J66HK5V@X8S4S=$Q38T5U36939G9E
M:#=/,5A(2&A0,40W;B8C>$$[<F5A=#)40R]Z;59M+TQ,6%%O2E!P4FUG,S)%
M.%I**S=-=E%F,S!81S%N.3%,,U!K:3)K5T\T:6MB-TM/<D=N9T183W!K3$1Y
M.$159R8C>$$[6#!4-6<O-7E".&DV:&]/<%=%158X2C=U,6YG:4Q1;T8U4U)S
M:3%):T\Q5&UH>&1M6EEY0DYB1C,X*S!S4FE2=2MC8S9"-34Y<RM4=B8C>$$[
M*U52,% O=&XR=CA!>5I83T]Z+S-K=F58<TUF,&HS2G9L5$XR2W9.=GIR+TUE
M3'EX;U0V6EEY+S=N9%-J2U%H5#A534Q65G!J5&-(<28C>$$[13DY*S)B1',O
M4V5*3&E0,&AW9&1Q:&IJ42MO+VDS:T@U3B]L:DXU<C%D9%(Q0TEJ>2]9=41/
M5S)%.&DW:49F169Z*S(S9DYR<CE9328C>$$[56%(,4@W2%9A1%(K2DQI;#E)
M*S$Y54%!04%#9T=W0395>FUN;S-9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-R8C>$$[1EA9<3=&578X=V%(638W;W0U<$8X=DLQ=EEZ
M1R]I1#%6:#=Q=T1$,T=767-H:$E32$U-36M"3TII95)F1S-M=GEX<5AL;EAB
M<E(Y428C>$$[5VLQ=3-W4T%F1$I'9G-32B]K<U V9&,V>D1M1U-):TAL32M%
M-#5'2E,K>'9R=7=V26)Y>FUA0S9T,T5K37E':DMY;6])3U=3:4I#:B8C>$$[
M>5E1;5EM>'IF4V8U6B]N;'!/=E)1-EHU9VM3=S%O04ES-U530S1.3V]B;VIN
M*U4W94AH;E!A=G,V54XT8G@K-39$4V1O4GEB4S)L.28C>$$[-S%/94-'-&=K
M9VYJ5U=#6E1(3$4T1$MY34M-<D$W145:<E%A3F@R2D9V2V1A+S5X=SAN6'1Y
M,"MN,U9Z<&=C,4YU<%=7268V;V-C>"8C>$$[.4Q(3FYJ-U9Y05510S8S2C)8
M:FMB1FA,9BMH661'+S9V;'HO04UI62]W0W579GEV3"MA1T@X:W<W>3<O04M&
M:#!B+W$K6% O04-*:B8C>$$[+W)J+T%#=DPK848O:VU(95AS3VLR0S9D<%9N
M<#9/6D5S-$ER9%I#2T9H16=116HS<&UP;DQI:U0S=3!I2T9)<DEP96(O;50K
M9$]I928C>$$[5F\U8D14;5159&5&5CE"5%=+0G9'6FPW:BM11W9J5$YH<$Y"
M3$IU9&]U1'%T9$A&<TXU9FIM.'DX;69L6#5Q."]A<S-M4'I63$YB-B8C>$$[
M9&-V-FMS,&YW>C-!-TQ#:$AW2E193E-L4'-G.71J<4Y:1$)(9VAZ*S4Q*T12
M>GI3-#AN2CE&-EAP96XV5EE1-F9P,75L<EHR-CA9628C>$$[27A25DA8-WED
M>50Q>E%4;5I'>G5895)I26EH>5)74EI/>%8R2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5C)+=7A6,B8C>$$[2W5X5F@S-6QF;'1P;FY84W94
M8VDS,6$R0DYH9E4K>51V-F-L3W-B9F@Q2'9L-E16>7=Y+V\Y430R<3!S8W-A
M4%!O6'EL-6<X=39X-28C>$$[9C%/6%1D5W1M=&)U3&9I,U)L4%(P66)-<#=%
M6C K3$Q(2DAI:6)$>D]81DQ(3&AK171Y>'):>#51+T]0>G0U6E9)26)O6#)N
M<'-,2R8C>$$[.'))<6IW4C9H,#EG1W W6FA:.4)J>6(Q4CAN3G=A+TIJ,C5J
M>F5R84PO>FMT-5IU1E9D6# V-7-*93=W;&)I3W9F9CDR-"\T135R328C>$$[
M;EI->#E*0F1L:C=6>&XV9U%Y,C$O3VHX<W)H07EA-4=M,5-S<V,P6DAT.&%$
M354V1$U0-%A+:G)C2B]I0S9F.#5F>7IG6&LK=7=K9B8C>$$[.%9X>E-(-VM2
M:F='9WI(*T9:83-%4#1G;$4O-3-73C!F5#AT*U@Y5C%Y62]:36-$4GAE,5AO
M-T0O9TUT2%HU2#%Y:D@T<T1R469P:B8C>$$[2UAW4V4Y,#<X.5!/871$9%!"
M-54P:5%584M.+S,W261Q355,>44P3S1*44AW>39-=$YH-65U6#0O2%9Q;$A5
M6F5D46HY=C0K4V8X028C>$$[:S,X:B]*=FPQ,'5R:4TV=G%355E83C!!559H
M,VIH,U5F-TQK4C0U4FXW4GE:3F@V4C5.=41163AE+TTK8C!034)Z6%EQ-T98
M67$W1B8C>$$[6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&56LX,2M49DPS;7)4+W%7<S)O;5)A;4=:9FAL:5DO="8C>$$[
M4G5.>#AU:#=J3'-/965-,T5T5UA$2$E+:TAG4&Y,+VY(=GI2<$QV8V%%,S9:
M<T)5:4YA2F1)4&5-;6HO04]W3E0O2TTS;41T4T5T<"8C>$$[96LO63984#)8
M3T\X4%50=&586%9N9#)C-U<Y,T)*8GIP<SA-<7-J9RLV<T%2;7EJ24572%=3
M:5EM:4M58VMH,DMV=4133$-X4W=S-28C>$$[170T;&M%35I$<6EH<6Q",T%Z
M:EIY3FYD-T=),E1$2S)4<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69"8C>$$[:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-644=R
M84)O97-296QQ=&AB,S!91D%*-#!K<"]Q;&=34&]Y8TUS;V934T=%-%)K2TET
M:%=P9B8C>$$[:THK5S$V>&%/>&QS;5!5,C W9V8X1$E:1D@P1$UY2&%7661B
M8U=86BM%.45L;B\U>&XX;7-164Y3,4=0<GE$=$$O>7!32DUU2&$K5"8C>$$[
M<4$P;G-R2#-Y+TAW9717.$MW5SA52VML66M6050Q2555>E9K,F)D;49407)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5B8C>$$[9&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69"8C>$$[:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:28C>$$[<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<B8C>$$[<U9D:7)S5F1I<G-69&ER>5AZ1"]!335$859O=74S*VMY85!0
M3DI95'E7-U-R2V=$1TYI=%%#3SE-,FU,<W55-&E814XS6%IE,&]1:R8C>$$[
M66M(6DQV.$%O6C=2=BMR2&,O.$%)-E K;5=F>5),*V-'=CA!;&%(8U58<#,O
M3U,O;%=A8TIF86)E5VM:,D5Q96Y-0B]R0W%';GER:R8C>$$[2F1K>D$R24Q+
M4&%U36YC15!5=$4Q,U(Y8S Y3E$P;39J=DQ/4V]75TTY0T]Q<T12;%EE0D9C
M,7542$M"<5%O=7=H3TUH8U199'(R<28C>$$[3'!/:#9J<7)2;5ID4'1P<F]X
M03A3-&AJ36Y'=$13=D=M3T](1DE2-WI3-4HX351,=41#9GDS+T]#,S@W-G1C
M-F9(<&(R2G1O1&-'4B8C>$$[<&A,5VIQ;D=G4E U<WI.6&]4:&E$9#(T=6PQ
M;WI%9T-Q96E:9T]A>$AZ:BMA=FLS>6Y,.5<Q2S9A5R]O1TYJ8DPV<W="1E%7
M,U9%+R8C>$$[,E1!-6Q93DAK>3=G8F0W:EHY6&IX9E5D,D-Y+S@U3S9!2$EI
M,%<V95 Y;&UK:E5N-6=C=C$U;6IS:68X-$](+T%#=$1U2WHO04M'928C>$$[
M,&(O<7@S4"]!0T]J+W!H+VMI6#@T3"]+,$\T=E$O>3@X.3)V;EA26CE6=')6
M-TY)8FQR57A334A*2U)P2GEQ05 Y*UIG87)42$1,:"8C>$$[2G9:>F1.<4)L
M:GA$=E1B>DQR4S9(;T8O<D121V1B0T8U>D-'-&QU07)4;%$P*S=+<T]0:FM)
M.3=B:VYW4DUU-6E0-6$O;35"-30Q0R8C>$$[.',T.4UA>$YP14II-U1#6&Q6
M=4Y+0D5P;59Q.4-C24)U-V-B4S9W6FEA1E4Y07I"8W@U6'$S-2LV5'!(;D,T
M,$,O,'E33S-T8FHV=B8C>$$[3G%#>6AG;R\S-3980W1"6&-C<S)C3WI:4W@X
M65!-8VY8-4\P27=Y8T)(>&5O=WI1>G=X>G=U<VM-<6@T-45)2W-R0V]91611
M4FUT228C>$$[<EHR04LO07)Y=GIN*V8X06]N;#=86G1)=&)"=%5A,BM'-6YJ
M;45A3$PK,4=0:&9L>#=N>#(W6G,Y4#):3$I(:4IQ,U@U*S!9635C3B8C>$$[
M5SE1='!H4&)25&=C4DMI=G@V,#5#=$TQ<$9';EE"57=+>#=Z,S4P,#=Y9F]%
M;7(S:2MS47EX5SES<D)7;&MB.6M%9S!O;TQ%,#9$3"8C>$$[.4YP>FQL=VAP
M>C5X:6IX1FEF:T@X.#E*.#)A-DY':W-',#)E5D=A,60U:$ES:G)U63EK4V@T
M,4DK5UI7<#=/;&EJ>%AB:F%F6'AY>28C>$$[-&%O=E1C,7IN=7A6-6(U-B]0
M4S(X<"M:8FY1-4Y(93=A,U=.:D]S-&I".5)!+S)3:F1/6&IM>3 S6GAY=T5U
M2VY!,4=V:FEL=VM7:R8C>$$[2"]1,$9L+S%,,&XO045L3"]W0E5S=CA!-4A0
M.#<W1VHK5F\O>E,W+T%+1V=S=CA!<5AP4"MK<&8K<5=0.&IN*V0Y:2]Y=$@K
M85AP2"8C>$$[-68X035H85(U,3 R83=S235,96$Q8U(S5G),5&MH6595:&QQ
M0W)B,"M85$YF<61,3$-A4%9Z=%!Q6359,D=5:V=#<#)!>D=C:#5P-28C>$$[
M;"]0+T%-:F%08U-7='%:=%=U27IX63)O6#!E43=E<3552#5Q1WI9-'5Z37-X
M6CE0=F-$3#)J:6=A-6YY63 S+T%$;$)90FIX.'9Y;"8C>$$[97A.>6]0,V5M
M8WE0-4A0.#<W1VHK5F\O>E-M2&QZ+VY):3 Q<EAT4#!H9$1K9V$O;FIT>$UB
M9TU%.5)G=DQJ-EER4W9J;&58<W-W:28C>$$[6F-83'EB35AA55IY15%$=3AV
M,4M'1V8X.5=H;5):65IF355A4WA/07ES<EAA:&Q:5'-14C%'8DM"<E1F-6XV
M2%<U0B]H6"MC2#!Z+R8C>$$[04E/.&\O.$%6:C O+W!&:"]W0V%C-3-X.&XX
M-"].-DAW-#EW4T1Z;"M5,VLO6'1(=4E)3DUT-TQ50D=X=$QU,6I31C%K07%V
M3&=&1"8C>$$[2U1S43-B=WDO0G)C:TI!,E-':E!P36515E<O93AB+S5X,#$V
M-W,O3W)A4W)%,F5P=U-E<$98-%)*0W9Q23E02&E'6#9C,C-A=4U(2"8C>$$[
M>&11-G)S<DE237@V15!F4% S+TM#95DO*S)892]W1%5/*V%45&8S<V8V=RLY
M,T]P+W5P9C%4.7IW-R]N1V(O;$QT52\W6C4O-5!2-28C>$$[=64Q+S=S93DQ
M2%I0,5,Y>C-V>E9Q-V%.-6$Q5%9604UL:F%Z5'AQ4E5&,%%L06%D:3%-,&U'
M2$A-4C=Y-VY,4&AI6F1W9DUF-54K5"8C>$$[,#@K96-R9S8Q3DI,8E)).3=F
M=GE)95HR8T%+5S=C;6%P4&=.<S9,5S4O07AJ:#EW968P941X.&A-+VDK:6]F
M>38O3'EX=%-"-64P+R8C>$$[,%EW5UHU<F%/6F=!3C9V27)U96YJ;6=/<7EY
M4#%(-74Y1VUX1"M'4'E9;"]I;B]N2&(O9D]J+SEW,&8Y54UY=D(Q9CE,+U1F
M=&-B>"8C>$$[3DPO42M43E!*96]E5$PW4S5:9DM+,GEA87,W2DU,4T0V=D@V
M-%)#,54T4C%B9U8S<&U*<4DU0DPY-60K8FQ91&I).496-4EF.'HO+R8C>$$[
M04-8;FU(+VU";2\T:FMT2"]E>#DV3E8O9%,Y>&5/+S@T>"\X<$1R4"]-26XO
M2C!:=&4Q+V]J-S-6.6MC-69".44U;UAD=FLW>FHU928C>$$[=B]-4#5V83%P
M1VYH5&581GAC=$-R1V=:;UE7;30Q.%<Y3V<Y.#9F0FQ'4%1X:V561#<S;3E2
M:4]454=)-2]S6F8K4C,U;E,V5F1J>28C>$$[9#5G9&]O1$E9.4]M;7%$0DYY
M;V)D*UA25V(W4#AR8F0Y<UAT2%(X43A32'@O5S586BMR-%0T8R]H*W!L+W=#
M9&8U<$1Y-5EN43E);"8C>$$[2#9E=D4O95-+86TR:&(Y<C)K8V9:.%!T949C
M5',O4BM)94M8,&HW6$LQ*W(X36--9G%0,E!N,WI2-58Q6'DW3' X5W%$:&0V
M:%IP9B8C>$$[;44O8FI75U-21E8O.'%K9DDK1F%D8S,R2$Y(2F9$>4)P,%=F
M1$Q'4GAC>4QF6FUL+W=$2$UT4"M-368O04)!6GE-+W%,,6<U26Y)<"8C>$$[
M9DY(;G)6-S,X>G9Z3'1F3"ML4U8P=3)K83-T<$)U;D9D-VDU4#!,.%!I05!(
M3VDP,$)P.$IN3#9J*T%(439I6C%'65%J.4DO0DMN*R8C>$$[8UAK42M33F4P
M-UA03#1A,3 K5# O<3=)5%=#-F=!-RM,:&5F>C59-D15*TY%>&YU9C!),3)N
M.$=1;D199G!E.&9L.35X='9.=FQE,28C>$$[,65+:51K96QE=TPO04QR;E%$
M;74O63%$3#=%6G!D5F=/2UII-VI4-6AK9TI":V59-V4K5B]W03A74F9Z6'9'
M9C=#:3!,5CA"0VQC-B8C>$$[6',W*S1(>&5E-U%.6CDO2C=&+WES5#AK4"M7
M;E0O.$%P1&8O04MO-7%F>75P-VHX+W="<G1V>E=$=D1'+W=!>&9/,S536"]K
M=E9,5"8C>$$[4W!B3U15<&]G='%K5G%Y4'HU<6%H:D=T2V9036I3-F902$E$
M2S8Y-VHV<E595&I)0D8P;V8X-'8O=T,X6&U(+T%)>5=V+T5:8VPR>"8C>$$[
M>FHX5TA:4#!Y.3=*+W=$;DE$>D)D-E0U1$U.<$E9<'14=45T2%I44G922TTX
M;$0W.$%P.6IM4#)::45S=2]15S,Y;S541$9T,3)92"8C>$$[*U)(-5EA0G(R
M;EA/=C8U0TQY3T]C,C%P84U3239O<7,P:F=5-69B04%/,UAB<&UB,FQR2E%)
M:$A:=RMZ=$I'565/470W86YK=GEC:28C>$$[:%4P3%1L561&1G!!05 X06A-
M,#-J-5 U>"MB='AI9T]12'E665!+=FQI,VU394133$M'94IG,&-S9'1%<DMW
M,T)69W114F=/85HR2B8C>$$[4'I336-2,$0U9S%I.'1R3#@W-6)Y-FM%5G1B
M95E&;6YL8F]S8V0P1UIJ5'=!>G!-8U-D3E$U.$@V2&YS<$$Q3FXK8T@P5B]Y
M=% X028C>$$[3'8P+U4O>$):.&%6<#9N>%4O,65U840X;FPO;6PS;C5R1B]/
M2'I9=C4Q+U!J>69P*VLS165I6%HQ3%9:63)3,T5+=4DT,EE55C-K628C>$$[
M2U!H-C!7<"M76D]N-TYY4VM/259&>#@O84=/23E*<W90=CA!;DA0>79F,UAM
M;"]-1%)S;6XV9$9*1W-X2'=V4$MV1&=P-SA566LK1R8C>$$[,VIM9C)R;4%H
M=V13-%!:5T5M4FXP939E9G8X06Q"4$UF+V),=F8X07%(9DY,<'8W,E X05=(
M,W4T,5 Y,4PK<69U94AF.#1Z9CAP9"8C>$$[<6XO8E!0.$%Y96IZ8SER+T%.
M,E!E-FIS;C9P934W-S5M,&HY32M89%0P;6]6<C8Q;6=2:C!6<$5+<3(S9S%$
M;6IW>C1*:5AC6&1:628C>$$[8U542'9$-6HO2S=Z6B]Y<B]W038S365U=U-1
M=T]J,E=O249*948Q8T50>$@R=4I8=#)/,F1(<DU(:C1X=RLX4% V4$XT1U%I
M93-E*R8C>$$[9T<O33<X=4QY,%IF.%%7:7AZ;WEM<VY"=T=&1#A,9T5(-6I.
M1BM4>D$O4UAD+VUS4B]I2'IE1V5E=DIN-51A6#5C;7903&YM2U159"8C>$$[
M5E(T>$9A=F-14T%Q>D%/94M223)Y-SEC,U=M,4=E539N1V\K-"]R9$YQ3E!G
M:D%M17)L-W<Y2"]!3V-A4"M5178O.$%T<5,O.5$X1R8C>$$[82]T8BLY2#E8
M.4IC-W-N*S90.$%7+U%'6B]M9B]W0U,X.'<O.'=-,R]%8WA.2"]E>#DW;6%R
M*S9L-VDX9"\U>&HO-5-(5V8K65)0*R8C>$$[5&]Z83ER+U)(,W5R-TDU>2M$
M-DIZ474W9D\R9R]W1')4178O041&,W8O54A,;2MY9C1N.$(Y-W!)+S0U*U U
M<64O;G8K5FXQ>4]8>B8C>$$[8F]K2BMU4DQY,5<R:D@Y-&EJ*R]51#EP4CEV
M>$<O63%P-TXQ;&9U-6-U;C9M-W1$4CA1-#0X*W%59FML*UA.,7)M;VIZ<#5J
M-3-%0R8C>$$[4'ES1FY*6G U:S(Y6G585DEY2TPW:G='5SEO86]12&AW*TQ6
M;TY-6FYX6C<Y,S8P<R\U>5@O-51U=R\W6F-8+T%&150U6C)4+V1(*R8C>$$[
M="MG3E!A,SDV4#9V-E,K:F1,+S0U;' O>&AJ+T%/241.0E V:3<X8VYN6#4W
M*V90.%!E5R]W0D4R8VY(5F195F]W5D\X5G8P:V9X0B8C>$$[879"9G!08DTO
M<S-494I0:5 P>"LY=V4P3E0T8TM(,5-E4F539DDO-7A7:T5E=2M6-THT23<K
M1VMD>4IB4D=E1FE$.6U:=W=$1E%E;28C>$$[+UA.<G%.4G!Y94=:-64Y,5=N
M=V%I231O1&XW=C!P,W)F;$@O04IY2#%Z5#(P+U9O2DQU>F1L6F]8;C K;DI4
M545%3T-$.'-P>#4Y2B8C>$$[03-(62LV5&1K>&%U67%7-"]W03%+=GEL.#-8
M;FMB>G).<$]S:')A>75P4'%E<%)0,&AM4FEQ4V)';G=T<U0O2V$K1U<V,T%-
M,E!I:B8C>$$[>D<T83E$;4](2G=3,D(K.3E3-7I4,%0U5R]02TY:4'I8=EDR
M*WDT=$9B-4=&0FY3.6Y'<T$K3'HS84%V4%AU96PK65 K8V-F2S R;"8C>$$[
M>7)O8S Q<G%9*TM#4V54,4EI4BMY-#0Q05!I3VUA+T8R<DU3.5<T8R],,EIJ
M3694<UAI5FIP=6YA0C5L9E103S)M6$%H:F)H8TI#-28C>$$[:FUJ.$I%-G))
M<$<O=4]H>F-3;5IW-'-:1'%)46IJ;G<U42MP+TE';"M43$1Y+T<S;$99>G!D
M>696.5I'85)N96Q$>EIY5S5#;$]*-B8C>$$[94%Z;7144$I+9C=Z;4AO=%!$
M2$=0;RML269Z,#AR,V5V95):9G%59G$S96UZ3&5P1V]Q-TEI<VMI<B]S6#55
M-S!Y+W,W34E:9"M2,B8C>$$[861F:$]42'1Z1S=Z6#AJ9GI5,$QY-5DS3VAA
M-TEB5S)L;4YX83-N1FY1339Q<DDO049H.6=%1VYJ6$YH,FIO<%I#2E(S3&=D
M;C9Y328C>$$[0G=3,F5X<"MA6#5D=6]995E,24$Y2WEH5#EX;V,Q4#503"].
M3'10>E=,*V-0;6E,4#AW+TDY-V1W,FQP<FQN4&-Z=4DT655L57-Z<R8C>$$[
M84)14$4U1U=L>4%766UM5612:DIO4T8K.312-3,O-54S+VI$5V8P;B]I3#E)
M+UA*=G)F,6(V:C90<3AZ>3E0;CA81W93=2MB=E0O;28C>$$[4$1J=SA&5C5U
M;3%89V5)94QJ=GEP22\K444O.2]2+S-,.'4O=VXO82]W1%I/4#A!-$XO5"]W
M0FEN9FQR+V]89C8P;C%Z.4Q5<G0K:R8C>$$[<65N5W4S3#9N=CA!=WEN3"MB
M<F)H*T@W6$IW+VQ/="](.6HV2C!$.4)F;VDR+U%8;V9O;F@O;W8Q6&HV4$@O
M2C1B9&5V=FUH>3A8128C>$$[94PV=DXS8T]':'<X;$AZ9CE1+W=N<E@V43E8
M-F@Y475V<FXQ9FHV,V\K:3-Q96YZ*TAN>')X-6)6=S1,.%-.8S=$2%!80DLK
M5D8U5B8C>$$[*U)N+T%#<FXO160O+VAF.4UF6%!Q6CEB.4HO5F93.4PQ52MZ
M-DAX8W563W4Q33)F85!J8T$T*T=R-E@K;#$S6C-H8U(T3TPT,2MH-R8C>$$[
M6&UN9',X>"].<B]L54A*9CA7.&8P='A(<&963U@Q>FHR-6-.<54V97)T-%IS
M9$8K62]Y9C K9DPX935W3EHT2"M5-2]A.&)F+VQ22"8C>$$[3G%F-&YP53 T
M+U5+53EQ-R]F;3-(-7(K:"]S;E5(.'1F.&8R3&8X06M"4"]!2#E(+V-V>"]W
M04HO=T)R+W=":VHO0G8V9CA!<UAU4"8C>$$[-4AF-%0O=VYD+S19*W8X03%$
M-B]*-G8V5#E(,797.4=(;'@Y1#1E2$AJ5'97=6%B=$AX4$5(2%8Q,"M093=N
M<R]G-$1W6%8Y9F=Y8B8C>$$[>C4K:E X1S9X*VQF6"]2,S%75#8S.58T978V
M9%!I.5 Q4&<U949C>#E.>&5*2&@U,S%C:E56-&-R-54X,B])<B]L6&XV6C%0
M+T,S-B8C>$$[6"MS+U9L*W-F<%0V='<T8WA4:#9'+TMV:FUW-U(X6&A(2'<X
M*VPO<&-$<S=W<E!">&9'=C!06G,Q1'18:D]K9CAQ."\U6&Q*.5@O4R8C>$$[
M+W=$:6HV>F1C=E4K<F953V8Q850Q2U4O9F-E1F50=FTS;C1V-6)F:#1+2&9F
M4#5/<6HT6#5N*TQJ*T9C=FTY;4Y+1W94=EA.43=66B8C>$$[1#90<$HV4$@P
M<41H=W!X<#)P5&%M12MA=D5V>G@O-59T+VEY,"]X4"MM9G(O=T)1:CE,.4=F
M5F92.4@Q<'503#$O:34X=59E,4M:=28C>$$[3WIV1SA-.$A$5CEB.'4U,"]A
M2&<X630K2S8V5C5V86)$,'9Q3G8V6$PP=E-4,"M63UA(:4M6<'17;6%I6$UU
M,TA*-$XK6B\O04-R3"8C>$$[+T@Q>"]I=B]!0D(Y9G)$+T%(6#%0-FXV1D)W
M.5 O9&YP.6$O=%9R,WID85!X=D,Y2$)8>'0P,G,X2'AF,VY&93-D6#8S=F1P
M.58K<28C>$$[=R]63T@Q6# Q*W(K;E1H-F1"=S0P,C0X96UA4U8S=GID>498
M06PT2BMC9B]!0W%,+T=C;C9B+U,S-E@Y1TPV-2MI=G$S<#%P.$AQ928C>$$[
M=G8V;G X9G,W57 S<FTW,$AJ*T@V94AH.#<O439B6"M"-&YQ-'5,>7(Y3#)0
M>6(V9BM&=$PY3#8S-E Q9%!2+U-0<"]7+U1P.$AQ*R8C>$$[;#A(3&I4*T\K
M86Y0.5HU8RMN2C)U3#9">C5D96)X<C@P=CA!;%9V+T%#<U,T+U1V-F,O5$@K
M:F,O<5 Q5#9T+V1P=W V=C=Z-TY/5R8C>$$[8F92*TXT4' T94AF;F1U<C%F
M9RM-3TQI-'1U5E4Y.7I2=31E669N9B]W07$P*V]7=BM++U<K=C%(,5 Y2&5N
M.64Y3W U9C-N=RML6"8C>$$[*V9A=E1F3FPR9C0Q;G<K6&YY9&8R:#181#8O
M:%A.2E!Y5B]W;"ML-78X2F8T:RMQ55 Q-S8Y.5,K;V-U4'<K<'<K3&XO3'<K
M3'@K1R8C>$$[=5AD;V5*=R]V3T,K;%AB5C)F=U=E1&IR>G%N=%=A9#)R>$@X
M>78X06Q19C94;2]34$PY3#AJ.5HO43EE6$QV-FQ0,TA/=E@Y<7983B8C>$$[
M>'!0>EA$=#E0.4PX5S9R5F9L=4PQ9E8U4$\S+T%/5D5C:E0O04)04W!P5#9H
M5#9+-S5S4#A++S)V+UI/=5 U8BMN.6ED95-0*U9.+R8C>$$[-'<P8CE'9C1I
M+U-0,7E(-G Y6BMO*VHV=DUC9E4T9D9X<C%P=FQ/;R]-94A,:31+<GIB.4PT
M2&E$:#0W.#9F+S)1/3T\+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO
M>&UP.E1H=6UB;F%I;',^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM
M<"YI:60Z-3,Y8F8U,C$M,V4T-RTV9C1A+6$X-&$M-3)C,#=D-F$U965E/"]X
M;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX
M;7 N9&ED.C4S.6)F-3(Q+3-E-#<M-F8T82UA.#1A+34R8S W9#9A-65E93PO
M>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X
M/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I2
M96YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*
M(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^=75I9#HU
M83(Y8S4X9BTP,F8U+30Q,#@M83,S,"UE9#4R-3%F,&$U,&(\+W-T4F5F.FEN
M<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD
M:60Z,#(W-3!F8S,M-#1A9"TQ930Q+6(T8V0M8C4V.3<Q,3%D-V4R/"]S=%)E
M9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U
M;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\
M+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.G)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S
M/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP
M34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M.3-D8F0T,30M.#EE82UA,#1D+3@U,V$M93(R,C=E-F4U-F)F/"]S=$5V=#II
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(T
M+3 R+3(Q5#$S.C$R.C$T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O
M<B R."XP("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-3,Y8F8U,C$M
M,V4T-RTV9C1A+6$X-&$M-3)C,#=D-F$U965E/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(T+3 R+3(Q5#$S
M.C$S.C$W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B R."XP("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @
M(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z4W1A
M<G1U<%!R;V9I;&4^4')I;G0\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE
M/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z0W)E871O<E-U8E1O;VP^061O8F4@
M26QL=7-T<F%T;W(\+VEL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/@H@(" @
M(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^1F%L<V4\+WAM<%10
M9SI(87-6:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I
M<VEB;&54<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A
M;G-P87)E;F-Y/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z
M3E!A9V5S/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^,C U+C@P
M-S<P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^,3(V+C,W,C8P
M,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S
M=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @
M(" @(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y#>6%N/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" \<F1F.FQI/EEE;&QO=SPO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*
M(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM<%10
M9SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H
M($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM
M<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \
M+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(#QP9&8Z4')O9'5C97(^
M061O8F4@4$1&(&QI8G)A<GD@,3<N,# \+W!D9CI0<F]D=6-E<CX*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_;
M $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M ?_  !$( *8!$ ,!$0 "$0$#$0'_Q  >  $  @,! 0$! 0          "0H'
M" L&!0,$ ?_$ %,0   & @$"! (%! <4"P    $" P0%!@ '" D1"A(3(105
M%C$X>+<7&B(Y(R1!5[6VU1@9,E%46&%Q='>!E)66EZ>TT];7)2<S-#4V5G9Y
ML]3_Q  = 0$  @,! 0$!            !P@%!@D$ P(!_\0 51$  @(" @$#
M 00% PP/" $% 0(#!  %!A$2!Q,A,0@4(D$5-E%VM2,R8187&"0W4E5U@9&S
MM#,T0E168G%RDI.4H=+3U24U0U-TE='4L41C<Z6R_]H # ,!  (1 Q$ /P"_
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&<XJZ]3[J#5O8]X:Q'
M+G=2#2-N=F:,6;BUK2+)LU:3;U!LW39R23QKZ"**9$R)"D) (4"]NW?.A5+T
MUX%8UU)YN*:9GEIUGD=:HC=F>%&9B\91O)B2200>\YZW?4KGM;8W5AY7N52.
MY91$:T9$5$F=54)*'7I0  .OH,R[KWKP]2RB+H#([FK^R(] 2B$3L+6=$=H*
M ';N1>4JT+4[,L!P#L83SPG#W%,Y!$1'$W_0_P!.;RM[>GL:Z1AU[M#97E8?
MTK%:FM5@1_\ X.OV@YEM?ZX>HU%E]S<5]C&O_P +8:VDZG^AI:L-6R>_Z9^_
MV$9*1H;Q-QC+LHWDWQO330.*97]QT=/J"9'OV*<R&O+V[.*I.XBH)AV24Y"@
M)"H+&$#9&>\^S=\/)QOD1+ 'VZFZ@'R?J VPHK\?L_\ =Q^?GL#XR3-']I'M
MDCY)QT!3T)+FEG)*_D2NONL>Q^?_ +Q['704]]BP1Q=Y_<2>8K,AM$;BKMBL
M16HNGVOI<RU7V-&)ID [H[BF3Q&,P\:,A_8W,Q"HRL"!^WHRJQ3$,:!N3<$Y
M5Q%R-YJ+%>N6\4OQ 6=?*2>E"W("\*._U6&9HI^OK$""!//&>=\4Y<@.CV]>
MQ8\?)Z$I-;81@#MO*G.$F=4^C2PK+!_>RL/G-R,U#-OQC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8S#&W>1F@]!,"
MR6Z]RZSU8W41%=JG>+G UY]($*(AVBHN1?(R<LJ(E,!4(QH[7.)3 1,WE'MF
M-5Q_>[U_;TVGV6S8-XL:5.>PB'_^[)&C1Q#]K2.JC\SF'VO(-%HD]S<[C6ZQ
M2ODHO7(*[R#Y_P!BCD=9)3\'I8T=CT>A\9'E,=;S@0,V>L:TL^U=^64@F*$%
MI/2VP;._6.4WD\K,TS$5IF_*8P@4CA@Z<M#B8 *X'W[;_#Z,<Y]D6=E6U>AK
M'Y]_=;FA60#Z_B$,UEXR!V2LB*P /:YH,WK/P;WC6UMG:;VR._Y#2Z:_:D)!
MZZ3WHJR/_P Y'9#^39[*'ZE-KM(%5JO3?ZCKMHIV%)U9M*4:AD7(/82JHIVW
M:\<L*)P'S)J*)I^8HE-V !]O'+Z=5:W8L^H?IXKCZK7W-Z]XD'H@M5U<B]C\
MP">CV/RSUP^HMJUT:OIYZA.A^CV--1HAA^T"WM(FZ/U!('8^<I8[5Z;G4!0M
M%NM+GAQR &/F;%.S:",109*V/$6LE).GZ1%F]0">,*J2*Y2K B*J93E,!5#E
M ##<75^HG S6J55Y?H?<AKP0L9;\=5"T<:1DJUOV!T2.QY='KY(&4ZVGIWSP
M6;=IN([WVYK$\RB*C):<++*S@,M3WSV P\O'L ]_)'SFC]SU[?M<R8PNPJ/<
M*',AYA&)N=:FJO)@!! #B+"<9,77Z B &_8OT1$ 'L(YNM._0V,7O:^[4O0_
M'\K3LPV8OGZ?RD#NGS^7SFE7-??UTGL["E;HS?/\E<K35I/CX/X)T1O@_!^/
MC\\\?GKSR9]*&F9BNRL=/5^6DH*<B'B$A$S,,^=1DK%OVJ@*MGT=(LE4'C)X
MW5*51!RV62614*!TSE, #GSFAAL1206(HYX)4:.6&9%EBEC8=,DD;AD=&!(9
M6!4@]$$9](9IJ\L<]>62">)UDBFA=HI8I%/:O'(A5T=2 592&!'8(.65NG?X
M@?8.N'D%JGFZO);,UX<[:-C]WLVHN]E4](1*@DM=634@#L.#;%],[N502)>F
MZ17;Q=6YO%&[ E<_4#T&H;!)]IPM8];? :232NWAKK9^6*TG8]:^=CV$B8_<
M6)1%%- SFQGI_P"O-_7O!J^:-)LM>2L<>Z5?/8U >@&N(H_]H0+\%Y5 O*/)
MR;CE8Q</I%XI^RJE7[[K^S0MRI=KC&\Q7+/79!O*0TS&.B^9%VQ?-3J(K)B(
M&34*!@40735;KD37243+4F[2MZZW8HWZTU.Y5D:&Q6L1M%-#(OU1T8!@?H1\
M=,I#*2I!-MJ5VIL:E>]0LPVZ=J)9J]FNZR0S1..U='4D$?4$?56!5@&! ]3G
MESU8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,9H
MES4ZC/&'@E72O=QW 7UWDF)WE6U)3RM9G8MD)W.1%T6),Z;-H"#46353^D5F
M>1$0H=NY;L'#^12!@IN_#O3WDO-['AJ*GA2C<):VMORAU]8_!93+XLT\P4@_
M=ZR2R@,K.L<9\QI',O4+C7"*_GM[?G=D0O5U53QFV%D?(5O:\E6" E2/O%EX
MH25949Y (S7LCN<W5GZMUOF*1PYKR?&31C1\,;8K_"2+R,+ -%0*<J=LW>O&
M_/'%A(BLDX3@-20D-/ V624<QKI@163"?).$^E?I54BN\NL'DN[9/<KT)HTD
M,[CX[JZ59?86N2"#/M9IH/($+(LA6/(#CYMZJ>JMN:EQ&N.-Z1']NQ?AD>(0
M*?D"UN6C]]I^B&%?50Q3^+ O&T?<@DDXV] [BYKQXG?.3<_;.7.W7ZI)&;EK
M])RL;1AEA IE%DZRVE7$Q8SE$3(+KWBRV)G)$(FN,)'G$42QWR+UTY-L$-'C
M<%7BFI0&."*A'%)=$0)Z!LM$L-<'X8+2K5WC)*^](/Q&1..^A?&=>XO<DGM<
MLVTA$DTM^26.E[OYL*RRM+8/^Y9KMFPD@ ;V8S\":>AZVUWJR"0J^LJ'3==U
MML!"MX"CUB%JD,B"9?(3TXR"9,&91*7V P(^;L(]Q]QR'+VQV&SG:SLKUS86
M&[+3W;,UJ8]GL]RSN[GL_)_%DQT==K]9 M;6T:>OK+UXP4JT-6$=#H=10)&@
MZ'_%SVN>//9C&,\U;:73K]".JU>ZG6KK7'Q1*]@+;!1=CA'A1 2B5U%3#5XQ
M<%$IC%$%4#AV$0[=A'/35N6Z$RV*-JS3L)_,GJSRUYD_YLL+(Z_Y&&>:W3J7
MX6K7JM:Y7<=/!;@BL0N/ITT4RNC#KX^5.0R<I^@;PCWVUDI?6$*_XS[ <E55
M:R^M2?%T-9X8!!+YOK"3=%A4H]/O[,Z6^I!Q,!3'<* !B'E_C'KIS/1-'%LY
MDY)04@-%L3X7E0?7VME&IF+G^_N)='Y!1WV(@Y/Z%\,WJR2ZV&3C=]NRLNM'
MG19SWU[NME80A!W_ #*;TCV 2Q^0:F/.#IA<I."$F=[LRL(VG5KM\#."W-1B
MNY6C/55U!*S83AU6Z,C39UP42D)%6-JT2>N2N$X"0G4&JKL+4<+]2N,\XC":
MVR:NS1"\^GN^$5U H_')" S1VX%^29:[N47Q,\<#,%RJ_-?37DW!Y"^QK"UK
M'?P@W%(/+2<D_@2<E1)3G8?2*PJAV#""2=5+Y';D@9'^3$])_JGW/@AL-I1K
MV_E;-Q;N\PD%UJW==^YU_(OCIH'V-2&O<ZB+MH )J6>!:%!&T1:)@*@,XTB7
M2,1^J7IC3YQKWO48XJW)J4)^YV?PHM^- 6&ONM\ JWR*T['NM*WR?8:53+?I
M;ZG7.#[!*5Z26SQF[,HNUCY.U"1R%.PI+\E73X-F!!XV8@?P^\D3"_[6[' 7
M&O05MJLQ'6&LV:(CI^O3T0Z2?14U"2[1%_%RD<\0,=%TQ?LG"+IJX2.9-9%4
MAR"(&#*(V*\]2Q/5M125[-::2"Q!*I26&:%S'+%(C %7C=65E(!# @Y>^O8@
MMUX+56:.Q6LQ1SUYXF#Q30RH)(I8W4E61T8,K D$$$9]K/CGVQC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8R!/JX]8J%X;-)#0V@G$1:
M>3DK'$&9E%R(2E>TE'238JS.2FF9P4:R][>M5DWM>JKL#LH]LHVG[0@M'JQD
M)8IS]*?2.;E[Q[S>K+6XW%(?9B4M%/NI(V*O'"XZ>&BCJ4L6DZ>1@T%9ED$D
MU>#/5;U<AX@LFBT316N22Q@S2L%DKZ:.10R23(>UFO2(P>O5;M(U*V+(,;10
MV()NF;TU=J]3K:M@Y)<F;1<W.DVUH5<W6\3,F]7NV[+<@9)1Y4Z[,O3*N&T0
MQ2]!M9[.B(IQ#7X>MULA)/UW5;F[U(]1=7Z;:NOQWC=:FFY:L%ITH8D6GIJA
M["6K$*=*TKGR:M6;YE;RL6"8O%;$(^G'ISM/4G:3\BY)9N-IELEKEV:5VN;F
MTI!>K7F<EEB3\*V;(^(D\:]<"7MJ]X[7&MJ#J&DU[7&L*C!4:BU1@G&5^L5Q
M@C'14:T3$3&!-%( ,LY<K&4=/GSDZSZ1>K+OG[ER\<++J4KV.QO;:[8V.RMS
MW;UJ0RV+-B0R2R.?CY8_S54 )'&H6.-%6.-515474U^NHZFG7UVMJ04J56,1
M5ZU>-8XHT'[%'U9B2SNQ+R.6>1F=F8^WSQ9[<8QF$>3,U+UKC?R"L5?DGL-/
M0&D-KS4),1KA5G(Q4O%4.>?1LDP=HF(LU>L7B"+IJX2.55!=)-5,Q3E 0S7'
M(8K'(=#7GC2:"?=:N&:&10\<L4MZ!)(Y$8$,CHS*RD$,I((Z.87D<TM?CV^L
M02/#/!I=I-#-&Q22*6*C.\<D;J05='565@058 @]C.=+_/).?_\ 7E<D/]+E
MR_E7.@G];O@G_!#CO_VFG_Y6<_/ZXO//^%_(?_NMO_S<Z#O!:TV2\<+>*%RN
M,Y*6:V6KCQI^P62QS;U>1F9V<EZ'!OI26E9!T=1R]D)!XNLZ=NEU#K+KJG54
M.8YA$:$\WJUZ7,>4TZD$5:K5Y!MJ]:O BQPP017ITBBBC4!4CC10J*H 50 !
MT,OKPFU8N\.XM<N3RV;5KC^IL6;$SF2:>>6C \LLKL2SR2.Q9V8DLQ))).;5
MYJ^;1GPK/6*W=:],U*X0,/::M8XYU$3]=L$<TEX2:BWJ1D7<=*1C])=F^9N4
MC&36;N45$E"CV,4<^]:S8IV(;52>:K9KR++!8KR/#-#*A[22*6,JZ.I'892"
M#]#GPLUJ]RO-5MP0VJUB-HIZ]B-)H9HG'3QRQ2!D=&!Z*L""/J,I%]87H\+\
M2EI'D=QQCY*5XWRDBF%MJ1E',G*Z3E)-R5%I^W%C+O9/74D]638Q<J^46?U]
M^LUAIET\*[CY)S<[TD]6UY4L?'N0R1Q<BBC/W6UTL<6YBC4L_P"!0J1;")%+
MRQ( EB-7FA5/&2-:8^K?I(W%6DY#QZ.27CTL@^]5>VDETTDC +^,^3R:^1V"
M1RN2\#LD4K.'1S7PR>\@3+?/AS^=#ZQP]FX.;%F3NGE3CI"_:)=OUQ.L:M?%
ME4O&OT5%3 *A85\^2MM>:$]9<(Y_;">9*.A6*"53?M!\)2O-6YKKX0J6Y(Z.
M\6->@+/AU2O,!]#-&AJV'^%]R.J?F29V-LOL^<V>S#9X5L)B[U(Y+VD>1NV-
M;S!NT 2?D0.XM5T +>W):'8CAC46I\K#EGL8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QD8?5<Y]L.!/&Q]9H%9@[W;LI5_3M+PCLJ3@B,T
M#4AYJ\R+)7S Y@Z(Q=-GZZ)TE6[^>?5R$= FUEUG+>2O2[@DG.>1I6G61-+K
M@EO<3IVI,/D1#2C<=>,UYU:,$$-' EB=>VB"M&OJCSN/@W'7LP%'W.Q,E33P
MOTP6;P!FNR(?YT-)&60@@K).]>%^EE++1DXD<>MC\_\ ES3]6*SLS)6#:-LD
MK3M#8$DJK*RD96TEUK!L&[RCQX*OQ<L9J+L6 OU2DEK-(1<:HL520(.78Y7O
M]?P3BES:""&.#65(ZVMH1@112V"%KT*42(!X1>?@']L$Q5DED (C.4HXIH-C
MSSE=/6-/-+/L[4EK9WY"998ZRL9[]V5W)\Y?#R]OS($MF2*,L#(#G27U5JZB
MZ3UQ3-3:S@&E8HE!@&%;K,(R+V3:1S!+R HNJ;]E>2#U85G\K).3*/923=.Y
M%\LN\=+K'YV;39W=SL;FUV,[V;U^Q)9LS/\ 5Y)#V0H'PD:#I(HU 2*-4C15
M15 Z):O64M-KZ>JUL"5J-"!*]:%!\)'&.NV/U>1V[DED;MY96>1RSLQ.0,\&
M>_,;[>V[KC0VM[9MS;=KC:5KVD1@RMCL4H*PH,VXK)-6R"#9LDN]D9*1?.&T
M;$Q4<V=24K)NVD='M7+QRBB?(ZG4['>;&KJM55DN7[LGM5Z\709V\2[,S,52
M..-%:2661ECBC1I)&5%)&.VVVU^CUUK:[6U'3H4H_=L6)>_%%["JJJH9Y))'
M98XHHU:261TCC5G95-;[9_B<]4PL^[8:AXM7;8-?;KJ(H6&[[(B-9N7Q$S"0
M'3>!BJAL@Z;9?MZC<'<FU=^B8@N6C983H)V&UOV;=I- LFVY-2H3LH+5Z6OE
MV*H3\^+3RV]>"R_1O")E[["LPZ8UYV7VDM5#.\>IXS=OUU8A;%W8Q:UG ^/)
M8(JFQ(5C\KYR*WCUY*K=J-<MM>)/7VCJO9FLAX;(P8;%U]<Z(,T'($\D,0%N
MKDE7QE COR*L?CQC_F'Q?P7QS/XKT?0^*;^IZQ-AU7V=1K-IK=E_5>9OT??I
MWO9_00C]W[I8CG]KW/TP_A[GM^'GX/X]^7BW71U[:?:*.SUFQUIX@(1L*%RC
M[WZ=]SVOO=>2#W?;_0Z>?M^YY^'FGEUX^2]]BKKEF,K/G37Z=OV".&/W8-'_
M (<U[.;WJ!^O7,/WEW7\0L9TA]/_ -1>'_NUI?X?7S<G-0S;\8QGPK/6*]=:
MW/T^VPT=8JM:8>2K]C@)=JD]BYJ$F&BS"4BY%HL4R3EF^9KK-G"*A1*HDH8H
M_7GWK6;%.Q!;JS25[-6:.Q7GB8I+#-"XDBEC<=%71U#*1\@@'/A9K5[E>>I:
MACL5K4,E>Q!*H>*:&9#'+%(A[#(Z,58'X()&<WWJ9<+9#@MRMNFI&P/76NIE
M-.]Z?F7@G56D==V!T\+'L';HW_>9:JR+.2JDLN;TU'SF&"7]!!O*-B9T-]..
M8Q\WXO3VS>";"$FCMH4Z"Q["!4,CHO\ N8K4;QVHE^0BS>UY,T3'.>7J1PZ3
MA/*;FJ7S;7S 7M3,_9,FOL,XCC9O]U+5D22K*WP7:'W?%5E49@OB)O>3XR<F
M](;WC%UT UOL. FIE-L)P5D*DLZ",NT-^A^F))RH/YN'5 H";TWQO* CV#,W
MRS1Q\DXWNM'(JM^D=?8AA+==1VPON4YOGX[@MI#,/Z4&83B>\EXUR32[R)F'
MZ.OP33!>^Y*C-[5V'X^>IZDD\)_H<YU#6SEN\;MW;19-PU=(I.6SA$Y5$5VZ
MY"JHK)*%$2G353,4Y#E$2F*8# (@.<TF5D9D8%65BK*1T593T00?D$$$$?D<
MZ6JRNJNI#*RAE8'L,K#L$$?!!!!!_,9^V?G/UC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QG._P"L_P JWO*+G1LTK"2.ZUYI)ZZTMKYJFJ)V
M/I4]\Y;7&=0 AOAUU+'=_GCI&22(!W< WKS8ZBR4>W/E_O1[BZ<9X3K2\?AL
M-TB[F^Q #]VT5J<!_P!THKTO84QD]+.UA@%,C#* ^L/*'Y-S;9!)"VOTKOIJ
M" ]IU4D9;DX _"QL7/>82 =O M=22(U.3+>&4T(Q;5#D3R=D61%)67L,3H^I
MO5$P*LQBX./C+Q>$T#B'F.WF7L[12J&*($*M71( F,"@$B#[2&]=K?'^-1N1
M%%7EW5I ?PO+/)+2I%AW\-"D%X@$?2P#^S)?^S?HD6IR#DLB RS6(M+5<C\4
M<4$<=VZ%/U*S//1[/T\J_79/8%JK*P99_&,9 ?XCAVY;]/R$10<+(I/^1&N&
MCU--0Q".FQ*OL1\1NX*40!5$KQFT=%3. E!=L@J >=,@A.GV>E5N>3EE!*<?
MV#(2 2K&UKD+*?R)1W7L?/BS#Z$Y!GVA&9>!0A6(#[_7*X!(#**U]PK#\P'1
M&Z/QY*I^H&4S.*6OZUMCE%QOU;<V[EW4-D[YU#0K4T9NUF#MU7+AL"OU^<;M
M7S<2N&3A>,D'22+M Q5FZABK)& Y"B%O^4W[.JXSR+9TV5+>NT>VO57=!(BV
M*E">Q"S(WX7421J61OAAV#\'*?\ %J%;:\FX[K+BL]38[S4T;2(YC=J]N_7@
MF577ID9HY& =2&4GL$$#+CF_^A7T\=?Z'W9?*U0+ZVL=)U'LBW5]RXVE;G;=
MO-UNFS,S%+KM%WAD72*3]D@HJW6*9)8A3)J )#"&5%T7K=S^_O--1LWJ#5[N
MUUU2=5UE5&:&Q<AAE575>U)1V 8?*GY'R,MUO?1+@%#1[F]6HWUL4M5L;<#-
ML[3JLU>I--$64OTRAT4E3\,/@_!RC-EU\I1G37Z=OV".&/W8-'_AS7LYO>H'
MZ]<P_>7=?Q"QG2'T_P#U%X?^[6E_A]?-R<U#-OQC&,8RN1XDK0C&Z<5M;;]9
M,B#9-)[(;P,D]*F!3_0/9[<(M^FNJ0/,K\/<HBE@Q(MW3;A(29D13.Z5!:PG
MV=MZ]/E&QT3N?N^YUS3QH3\??M8WNQE0?@>5.:YYE?EO;C[["#QKW]HG1)<X
MOKMZB#[QIMBL$C@?/W'9+[3AB/D^-R*GX _"^Y)UT6/=);+F93/.H-PKLSNY
M\.>*%MD%#+2%EXW:/G)%4XB8ZDA)ZSK+M^<QA[B8QG:JPB81'S#W'N/?.:?,
M:RT^7<IJ( L=;D6Z@C '0$<6RLH@ _(> '7]&=+.&V7N<1XM;D),EGCNEGD)
M^IDDUM9W)_;VY)[_ #S9K-;S9,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&,8QF*-\[!'4FC=S[5+Y/-K/5&Q-@E]0H&3\U,J$Q8R^H40$#$$8T ,4
M0$#!W#L/?MF4T=#]*[O3ZL]@;+::^@>OK_;EN&O\?T_RGQF+WE_]%:3<;3X_
M]FZO87QWUUW3J36 #W\?/M_GG*^=NW3]VY?/7"SMZ]<+.W;IPH95PY=.5#+.
M'"ZIQ$ZJRRISJ*J'$3'.8QC"(B(YTZ1%C18T4(B*J(JCI550 JJ!\     ?0
M#.8KNTCM([%W=F=V8]LS,269B?DDDDDGZDY?A\/G',F73=I;EJ! 7E]H;6D9
M(2@'F,]2L18E,5/Z9_ET8P* CW'TRD#Z@  HQZ]2._J)<5N_&+6:N./O^\-<
MRGK^CW)'_P O>7H]!8T3T[ILO7E+LMI))U^;BQ[0[_I]N*,?\@&3;Y#&3-C&
M,@'\1_\ 8 K/WD-=?Q-V=D[?9Y_7NS^[NP_US69!7VAOU#K_ +PZ_P#U3994
M)X$_;FX9?>LX]?BW4<MASK]2>8?NOO\ ^%6\J=P7]=N'_O1H/XK4SHV<M/LJ
M\F?N^[F_#FR9SWXK^L_'/\?:?^(5\Z$<J_5CD?\ B'<?P^QG+ASIEG,W.FOT
M[?L$<,?NP:/_  YKV<WO4#]>N8?O+NOXA8SI#Z?_ *B\/_=K2_P^OFY.:AFW
MXQC&,9%SUI8YE)],;E4@^ @I(5VB2*(G !\KV+VU09%@)1'^A.+QJ@0HAV$?
M,)?J$0&3/1V1X_4GB[)WV;%V,]?WDNJOQR=_T>#,3_R?E]<C/UBC27TVY0K]
M="O1D'?]_%M:$B=?T^:J!_R]9SI<Z"9S[SJ,\1:<[UYQ1XR4*02,A(4KC[IJ
MJ2")RB51.0K^NJY%/BJ%'L)5 =-5?4 ?<#^;O[YS.Y7;2_RCDEZ,AH[F^W%J
M-A]"EC86)4(_H*N.OZ,Z8\4J/K^+<;HR#QDIZ'3U9%/U$D&OKQ.#_3Y*>_Z<
MV'S 9G\8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QFGG4+:NWG W
MF8W9 87!N+V]% *3N)SI(:ULB[E,H![F%1LDLF!0[B83>4 $1[#MW 61.<</
M9^@HY+I!V?H"=C753_D8@]_E]<U+GR._!^8*G98\9W9 'U(&NLE@!^TJ"/\
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M*!2@   93!F9F+,2S,2S,Q)9F)[))/R23\DGY)^3ET  H"J JJ %4    =
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M=V9W=BSNY+,S,269F))9F))))))))/>6/55151%5$10J(H"JJJ %55  55
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M]1.=NQ8\OY$"?J$VUR-?\BI*JC_(!DU)Z=\$10HXAQT@?0OJ:<C?Y6>)F/\
ME)SU-3X)\+:'9H.YTKBGQ^J=MK$FUF:[9:]J:E1$Y!R[%4JS*3BI-C#(O&#Y
MJL4JK=TV5362.4#$. AWSRVN;\QO5IZ=WE&^M5+,;PV*UC:W)H)XG'B\<L3S
M,CHP/3*P((^HSU5>$<.HV8+E+B^AJVZTBS5[-?54HIX)4/:212I"'1U/RK*0
M0?D'*1^\OUYLK_\ (;1OQEK.7-T7]Q.+]PK_ /";64RW7]VR3]_Z/\7K9T'<
MH5E]<P]N?D#I/CQ4Y&[;LV?3=;5R-9KO5'5GG&3!V^*@0Q_A82(,H:7L$FX$
MHI,HB$8R$F_<"1NS:+KG*F.6T^AW._M1TM-K;FQL2NJ!:T+NB%B!Y32]"*"-
M>^WEF>.)%[9W503F(W&^TW'ZLEW<[.GKJ\:,Y:S.D;OX@GPAB[,MB5NNDB@2
M261NE1&8@903@GLUU(.K6QL]$@I,D7N+DM%VQ!NLC^WJ_J6IS3!VZFYL$#*H
MM74/KFM_'R*95C(#)D%BV75.LW%2]<Z0^G?I4]:]/$9=1QR6J6!_!8VMJ&1$
MAA\NF99MA8]N,]!O:/N,JA6ZHK \WJ'ZJI9H02^UM^1Q6U5E_'!JJDT;M-.%
M)56AU]?W) &Z,@]M6)9>^B;G/[.@.<^;G/\ KK;Y]['4W^W4#+Z\+_N-4OW4
MVG^BO90OFO\ =EN_O5JO])0SH,Y0K+Z91G\1KIFRTOFQ [><,7)Z=NC5U;^4
MS/IG^"^D] *I6+%7P5$/*#QA$DJLPH3OV,WGT!()C$6 EUOL][BM<X;8U*NH
MN:?9V?=A\AY_=KWC9KV/'OOPDE-J$'^^KMW]032C[0FGLT^90;9HV^Y[C65_
M:FZ/A]YH UK$'?T\TB^ZRD?FLZ]?0]6P^!?+C4O+SCIK6\Z\MD%(V%I2JU';
M$I;>0:C9*'<6$4T8ST-.0OJ!(LFQ)1!R,-(KMDF4W%&:2<>JJV<D$*M<YXIM
M>)\@V-+859XZ[W+,FON-&WW>]4>5G@FAFZ]MV,3+[T:L7AE\XY K*<M+P;E>
MJY9Q_77=?:ADG2G6CV%-9%^\T;<<2QSPSP]^XBB56]F1E"31%)(R589@KJA]
M-QSU'*;JBIMMPH:@-K*S6*PF?KT-2]A-!/13&-!H5LG<*@,>+46?K"N*[T%@
M4]/T4O)YS9STS]1%]/;FUM-J&VWZ2K5ZX1;PH^S[$KR>98U+?N>7GUX^*>/7
M?9[Z&$]2_3MO4*GJZB[==3^C;,]@R-1-[WO?B2/P\1;J>WX^/EY>3]]]=#KL
MTG>HOP?5Z?\ OYAHM?9J.UU7NNZ[?C69&H'I)$/I!+6.,+$_)SV:UF4,U+
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MJ]!]YO\ DNYWE;>ZNM%L]C/=ABEBN&:%97\U5VC0KYK^U3UW\@YA(OAO>6Y
M$"<MM9D ?<0*&S"@(_TQ[- S-'[0_%#]>*;(_P#*=;_XLPW]CSRS_A9KO_\
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M5H<IX3J^*P:FY4L:]M47MS3PR0R?HZG)5?QC10X]QG#KV?@#H_.0CPKTIO\
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$^N?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
